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EDIBLES UTLIZING MULTIDIMENSIONAL LIQUID CHROMATOGRAPHY 
TANDEM MASS SPECTROMETRY 
 
KAYLA M. BENVENUTO 
 
ABSTRACT 
Synthetic cannabinoids (SCs), present a multitude of problems in terms of 
maintaining up-to-date, reliable, specific, and sensitive methods of detection. Synthetic 
cannabinoids are novel psychoactive substances originally synthesized for medical use 
and research purposes. Abuse of these compounds, however, has demonstrated a variety 
of effects ranging from euphoria to aggressive behavior and loss of consciousness. The 
most dangerous reported result of synthetic cannabinoids use has been death. The number 
of synthetic cannabinoid compounds detected drastically increased from two to over 80 
compounds within six years. The marketing of these compounds, similar naming, and 
described pharmacological interactions, create the dangerous and very false perception 
that SCs are similar to, or the same as, tetrahydrocannabinol in cannabis products.  
 This research focused on the development of a method to detect and quantify 
seven synthetic cannabinoids in urine, plasma, and gummy bears. The seven synthetic 
cannabinoids studied include XLR-11, AB-PINACA 5-pentanoic acid metabolite, UR-
144 5-pentanoic acid metabolite, 5F-PB-22, AM-2201 4-hydroxypentyl metabolite, 
JWH-018, and JWH-018 5-hydroxypentyl metabolite. Sample preparation methods and a 
two dimensional liquid chromatography tandem mass spectrometry method were 
optimized and developed for analysis of the seven SCs in each matrix. The method was 
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successfully applied to 17 authentic urine case samples previously screened positive for 
synthetic cannabinoids and a calibration curve for each matrix was generated from spiked 
samples at varying concentrations. Utilizing two-dimensional (2D) chromatography for 
the analysis of synthetic cannabinoids allowed for a novel approach to be employed. With 
this method, 100% organic samples were analyzed with improved resolution and 
increased sensitivity. 
 The sample preparation method for the urine and plasma samples included a 
protein precipitation technique with acid followed by solid phase extraction (SPE) on a 
mixed-mode reversed phase strong anion exchange sorbent. The spiked gummy bear 
samples were prepared in 50% methanol in water, dissolved by heating, and extracted 
with SPE on the same sorbent used for the urine and plasma samples. A 200µL injection 
of the 100% MeOH extracts was injected into 2D-LC-MS/MS for analysis with a loading 
and diluting solvent consisting of water and 2% ammonium hydroxide and elution 
solvents containing water or methanol with 0.5% formic acid. These conditions were 
optimized with an automated method development protocol assessing various conditions 
such as mobile phase solvents, pH additives, and trap column chemistries. The final 
chromatography method utilized an ACQUITY ultra performance liquid chromatography 
(UPLC) ethylene bridged hybrid (BEH) C8 2.1 x 30mm, 10µm trap column and an 
ACQUITY UPLC high strength silica with tri-functional C18 bonding (HSS T3) 
analytical column 2.1 x 150mm, 1.7µm.  
 The urine calibration curve produced had a linear dynamic range (LDR) of 0.05-
2.5ng/mL for UR-144 5-COOH and AB-PINACA 5-COOH and 0.05-5ng/mL for the 
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other five synthetic cannabinoids. R2 values included 0.992 and 0.993 for UR-144 5-
COOH and AB-PINACA 5-COOH, respectively and 0.995 or above for the other five 
compounds. Synthetic cannabinoids were detected at varying concentrations in all 17 
urine case samples. Analysis of plasma and gummy bear samples was also successfully 
carried out. Plasma calibration curves had a LDR 0.05-10ng/mL with all R2 values above 
0.995. Gummy bear calibration curves produced a LDR of 0.05-10ng/mL or 0.05-
2.5ng/mL with R2 values over 0.995. All extraction recovery values were greater than 
80% with the exception of 63% recovery for AB-PINACA 5-COOH in the gummy bear 
matrix. Suppression effects of 8%, 19%, and 6.6% were observed for urine, plasma, and 
gummy bears, respectively. Relatively low recovery values, reduced linear dynamic 
ranges, and suppression matrix effects for the carboxylic acid analytes assessed in this 
research suggested an alternative approach may be more successful for the analysis of 
these particular compound types in all three matrices. Overall, a sensitive, specific, and 
reliable method was developed with low limits of detection and quantification for 
efficient and rapid analysis of compounds at trace levels utilizing 2D-LC-MS/MS.  
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1. INTRODUCTION 
1.1 Background 
Synthetic cannabinoids are novel psychoactive compounds that have become 
increasingly popular with a dramatic expansion in terms of the number of compound 
types since they were first used illicitly. Typically, synthetic cannabinoids are a powder 
dissolved in a solvent and sprayed onto an herbal substance [1]. There have been a 
variety of street names used for these compounds including “Armageddon,” “aroma,” 
“Aztec gold,” “black mamba,” “cloud 9,” “demon,” “dream,” “Mad Hatter,” and “Mr. 
Nice Guy” [2]. These compounds are more commonly referred to as “Spice,” “K2,” and 
“SC” [1-3]. Spice compounds were originally synthesized for research purposes, as they 
are believed to have potential medical use [2]. They are studied medicinally for treatment 
of pain, “obesity, neurological diseases, emotional disturbances, and other psychiatric 
disorders including drug addiction” [4]. However, illicit use of SCs was described in 
Europe around 2004 and in the United States in 2008 [2, 5]. Since then, the popularity of 
synthetic cannabinoids has considerably increased. Additionally, there has been a 
significant growth in the types of compounds classified as synthetic cannabinoids. The 
compelling characteristics associated with their use such as ease of access, affordability, 
the potential for the substance to go undetected in standard drug testing methods, the 
ability to develop a stronger high in comparison to that associated with marijuana use, 
and the misconception that SCs are legal have undoubtedly played a role in the increased 
popularity and synthesis of synthetic cannabinoids [1, 2].  
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1.1.2 Types of Synthetic Cannabinoids, Classification, and Naming 
There are many different compounds classified as synthetic cannabinoids, and 
with slight structural modifications to each, the list continues to grow. The 
cyclohexylphenol CP-47, 497 and the aminoalkylindole JWH-018 were among the first 
compounds to be synthesized [6]. In addition to JWH-018, other compounds that are 
grouped in the napthoylindole classification include JWH-015, JWH-019, and JWH-122. 
Phenylacetylindoles, benzoylindoles, adamantylindoles, and dibenzopyrans are also 
described classes of synthetic cannabinoids [5-7]. SCs such as RCS-4 and AM-694 are 
classified as benzoylindoles while HU-210 is considered a dibenzopyran, or a classical 
cannabinoid [6]. There is a lengthy chemical name associated with each synthetic 
cannabinoid, such as N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide for the 
compound APICA and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide for AB-PINACA [8, 9]. However, the names more frequently used, like the 
ones previously listed, consist of a combination of different letters and numbers.  Many 
times, the name corresponds to the individual or company that synthesized the compound 
or the location where it was first analyzed. Other times, the name may be termed in a 
certain way by illegal manufacturers and dealers to appeal to their users. The ‘AM’ in 
AM-2201 and the ‘JWH’ in the JWH series refers to the individuals who synthesized 
each compound, Alexandros Makriyannis and John W. Huffman, respectively. On the 
other hand, XLR-11 was named after liquid rocket fuel and 2NE1 after a South Korean 
girl band [8]. Sometimes the name differs from one compound to another because of the 
structural modifications made such as the fluorine addition that creates the difference 
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between PB-22 and 5F-PB-22. Simple changes to compounds create major issues in 
keeping up with the manufacturing of certified reference materials and methods of 
detection for all of the synthetic cannabinoids that are synthesized.  
1.1.3 Manufacturing, Packaging, Sales, and Consumption 
SCs are manufactured as powders and “contain modified molecular structures of 
illegal or controlled substances” [2]. They are typically manufactured in China and then 
shipped in bulk [8]. The powder is dissolved in a solvent such as methanol or acetone and 
then sprayed onto an herbal-like matter, or dried plant substance. In addition to the 
synthetic cannabinoids, additives including vitamin E and clenbuterol, flavors, and even 
other drugs such as cannabis, amphetamines, cocaine, and Kratom may be encountered 
[1, 2]. SCs have also been detected in other mixtures such as those containing stimulants 
or hallucinogens, ecstasy tablets, and liquids for e-cigarettes [8].  
The plant matter with synthetic cannabinoids sprayed on is sold on the Internet or 
places such as head shops, gas stations, truck stops, and convenient stores in the form of 
incense, potpourri, and/or aromatherapy products [2, 5]. The false perception that these 
products are legal is often the result of the misleading labeling and marketing. Spice is 
commonly labeled ‘not for human consumption,’ ‘herbal incense,’ or ‘for aromatherapy 
only’ [2, 3, 6, 10]. They are also labeled in such a manner to avoid legal action or 
limitations on sales and distribution. Spice is typically packaged in shiny, metallic 
wrappers with bright colors and creative names. For example, some incense packets are 
named “Spice Gold” and “Yucatan Fire” [2, 8].  This type of packaging is utilized to gain 
the attention of young adults or first time users.  
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SC administration has been reported orally, rectally, and via vaporization with 
liquids utilized in electronic cigarette use. The primary method of administration, 
however, is smoking [11]. Unlike smoking marijuana, synthetic cannabinoids have a 
much stronger effect. 
1.1.4 Scheduling 
The scheduling of SCs has been difficult to keep up with since, with a slight 
structural modification, it is very easy for manufacturers to switch to the production of 
another synthetic cannabinoid once one structure becomes controlled [8]. The first major 
action taken to schedule SCs was in March 2011 when the United States Drug 
Enforcement Agency (DEA) listed JWH-018, JWH-073, JWH-200, CP-47, 497, and CP-
47, 497 C8 homologue as Schedule I drugs [5]. Then, in May 2013, UR-144, XLR-11, 
and AKB-48 were also scheduled as Schedule I under the controlled substances act [5]. 
The Synthetic Drug Abuse Prevention Act of 2012 was signed by President Obama in 
July 2012 scheduling JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, 
JWH-203, JWH-250, JWH-398, AM694, AM2201, RCS-4, RCS-8, HU- 210, CP 47,497-
C7, CP 47,497-C8 and their analogs as Schedule I controlled substances [1, 7]. On July 
26, 2012 “the US DEA conducted “Operation Log Jam,” seizing 18.4 million packets of 
synthetic cannabinoids, $36 million in cash, and arresting more than 90 people from 109 
US cities” [1]. More recently, the DEA temporarily placed AB-CHMINACA, AB-
PINACA, and THJ-2201 into Schedule I [9]. As a response to the continued legislation 
efforts, SC manufacturers are rapidly synthesizing new synthetic cannabinoid compounds 
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negatively impacts maintenance of up to date drug testing, the development of certified 
reference materials, legislative action, and the progress on research and treatment [7, 8]. 
1.2 Toxicology 
1.2.1 Cannabinoid Receptors and Comparison to Cannabis 
Synthetic cannabinoids elicit effects similar to those associated with the active 
ingredient in cannabis, tetrahydrocannabinol (THC). They also act on the same receptors 
in the body with agonistic effects. THC is the component of cannabis that contributes to 
the psychoactive effects often displayed when cannabis is used [8]. While SCs are 
commonly marketed and described as “synthetic marijuana” or as a substitute for 
cannabis, synthetic cannabinoids are very different from THC and the other natural 
cannabinoids present in the cannabis plant [1]. THC is a “low-efficacy partial agonist” 
and synthetic cannabinoids are “potent, full- and high-efficacy agonists”[1]. Furthermore, 
SCs have been described to be up to five times more potent than THC in marijuana, 
which enables stronger sympathomimetic and hallucinogenic effects [2].  
In the body, THC and SCs act on two currently characterized cannabinoid 
receptors, CB1 and CB2. These receptors are “G-protein coupled receptors that were 
discovered in the 1990s and also have endogenous ligands” [12]. Cannabinoid-1 
receptors are located in areas such as the heart, intestines, and liver and they are also 
largely present in the central nervous system. They are primarily responsible for the 
psychoactive effects that THC and SC compounds elicit. CB-2 receptors may possibly be 
located in the brain but they are mostly observed in the liver, lung, and kidney [13]. CB-2 
receptors are responsible for analgesic effects. SC compounds have 100 times the binding 
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affinity to CB-1 and CB-2 receptors as compared to THC [12, 14]. As a result of the 
interactions with the cannabinoid receptors, SCs can present a multitude of effects. 
1.2.2 Effects 
Most of the information known about the effects associated with synthetic 
cannabinoid abuse is learned from medical case reports, users on online Internet forums, 
emergency departments, and Poison Control Centers. The onset and duration of 
symptoms can vary. They can be immediate or develop hours after use and they may last 
up to several hours [1]. Most importantly, use has been linked to “serious health 
consequences, including seizures, renal failure, and death” [2]. SCs are also weak 
monoamine oxidase inhibitors, which can lead to serotonin syndrome. Euphoria, 
relaxation, increased creativity, tingling, and calmness are a few acute symptoms that 
have been described to be associated with SC use. Additional symptoms include altered 
mental status, dry mouth, cough, tachycardia, injected conjunctivae, rhabdomyolysis, 
acute kidney injury, cardiac arrhythmias, myocardial infarction, addiction, aggressive 
behavior, agitation, chest pain, hypertension, loss of consciousness, nausea, and 
restlessness [2, 15]. Panic attacks, psychosis, and suicidal attempts have also been 
reported where “psychosis related to Spice use has received particular attention both in 
the media and medical literature” [1].  It has been discussed many times that the effects 
connected to psychosis are what ultimately forces the individual abusing SCs to get help, 
such as asking for medical attention.  
In terms of chronic SC use, schizophrenia and possible memory loss are also 
concerns [2]. Another major area of concern is the effect SCs can have on driving 
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impairment. The sedating effects, fine motor skill impairment, blurry vision, pupillary 
changes, and light sensitivity could all play a role in affecting an individuals’ safe driving 
ability [1, 15]. The problem with the effects SCs demonstrate is that there is very little 
information known about the toxicology that is behind these outcomes. Furthermore, as a 
result of the “variation and complexity of [the] herbal blends,” it is difficult to gather 
information on the “cumulative effects” of SCs [6]. There can also be increased risks 
associated with SC use as a result of variations in the manufacturing processes. The SC 
solution may not be sprayed on to the herbal matter in an even distribution leading to 
some packages being more concentrated, and therefore much more potent, than others 
[8].  
In regards to treatment, there has not yet been an antidote developed specifically 
for synthetic cannabinoid intoxication. Effects that are common to other types of drug use 
or medical conditions, such as hallucinations, agitation, and seizures can be treated with 
other drugs such as benzodiazepines [2]. Until there is more information about the 
toxicological and pharmacological characteristics of SCs, there may be limited treatment 
options. 
1.2.3 Pharmacokinetics/Pharmacodynamics 
Since synthetic cannabinoids are novel substances, there is still very little 
information known about the toxicity [8]. For instance, the LD50 is unknown for many 
SCs and the list of synthetic cannabinoid compounds continues to dramatically increase, 
making it challenging to maintain an understanding of the pharmacokinetic and 
pharmacodynamic properties of each compound. The liver is a primary location for SC 
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metabolism in addition to other secondary areas such as the kidneys [16]. Most studies 
have been conducted using in vitro experiments yielding some useful information 
regarding SC metabolism. Through these experiments, it was concluded that the JWH-
018 metabolites consist of mono-, di-, and trihydroxylated forms in addition to N-
dealkylated, carboxylated, and/or dehydrogenated products where the major product 
tends to be the monohydroxylated compounds [6]. Synthetic cannabinoid metabolites can 
be derived from multiple parent compounds. For example, it has been largely discussed 
that the metabolite JWH-018 5-hydroxypentyl can be the metabolite of either JWH-018 
hydroxylation or AM-2201 defluorination [6, 16]. For SCs with a pentyl side chain, Diao 
and Huestis explained the major metabolic pathway to include hydroxylation followed by 
oxidation producing carboxylic acid and carbonyl metabolites [16]. They also described a 
similar pathway with fluoropentyl SCs after a defluorination step. For SCs with an ester 
linkage, ester hydrolysis appeared to be the major pathway producing carboxylic acid 
compounds [16]. Overall, the metabolites of the parent compounds are most prevalent in 
metabolic research that has been carried out thus far, emphasizing the importance and 
necessity of developing methods to detect all types of synthetic cannabinoids [16]. 
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1.3 Literature Review on Synthetic Cannabinoid Analysis Techniques  
1.3.1 Investigated Matrices and Sample Preparation 
There are several detection techniques that have been used to screen for synthetic 
cannabinoids, but the methods for quantitative analysis are restricted. The quantitative 
and qualitative methods currently utilized become limited as new compounds are 
synthesized. Sample preparation of synthetic cannabinoids ultimately depends on the 
matrix. There have been several matrices studied thus far including urine, serum, hair, 
oral fluids, herbal blends, chemical powders, whole blood, plasma, mouse tissue, and 
sewage [5, 6]. Urine is a widely used matrix as it is less invasive to obtain in comparison 
to other matrices, enabling larger sample volumes to be collected for testing.  It also 
allows for a longer window of detection and metabolites are commonly observed 
providing for additional verification. Preparation of urine typically involves a hydrolysis 
step with the use of a strong acid, base, or enzyme [6]. Synthetic cannabinoids in oral 
fluids have also been studied but such a matrix is less preferred over urine, perhaps 
because it possesses limiting qualities such as the slow rate of diffusion of SCs from the 
oral fluids into the bloodstream [6].  
The sample preparation of herbal blends is fast and easy as long as the samples 
are representative since the synthetic cannabinoids may not be distributed evenly in 
concentration and volume throughout the herbal substrate [6]. Solid phase extraction 
(SPE) and liquid-liquid extraction (LLE) have been reported sample preparation 
techniques of biological matrices demonstrating “nearly identical results” when 
comparing the two methods [6]. LLE has been described to be a useful extraction method 
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for SCs in biological matrices because they are highly hydrophobic compounds [17]. Yet, 
SPE has also been discussed as a primary method used in the analysis of biological 
matrices because it allows the best purification and concentration of target analytes while 
minimizing “matrix [effects] and [improving] the results of mass spectrometry (MS) 
measurements” [6]. It was suggested that SPE might have better results over LLE for 
some SCs, such as the carboxylic acid metabolites, which are an important analyte of 
interest when studying a urine matrix [6].  
1.3.2 Urine, Plasma, and Edible Matrices 
1.3.2.1 Urine 
Urine is a common matrix in the analysis of many illicit substances. Typical 
sample preparation in SC urine analysis includes SPE or LLE techniques [6, 17, 18]. One 
method prepared authentic urine specimens with 10µL of urine, 10µL of internal standard 
stock solution, 10µL of methanol, 50µL of 0.4 M ammonium acetate buffer, and 2000 
units of beta-glucuronidase [19]. This solution was vortexed, incubated, cooled, 
precipitated, vortexed for a second time, and centrifuged resulting in a total preparation 
time greater than two hours. Furthermore, the study was limited as only 5µL of the 
sample was injected “to reduce possibility of MS contamination” [19]. Another study 
used a salting out technique in combination with LLE. The samples were hydrolyzed with 
beta-glucuronidase, vortexed, centrifuged, and the organic layer was diluted with formic 
acid and water before liquid chromatography tandem mass spectrometry (LC-MS/MS) 
analysis [20]. While this method allowed a quick and simple preparation, the authors 
discussed the desire to develop a lower limit of detection (LOD), which may have been 
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enhanced with injection of the 100% organic sample obtained from the LLE rather than 
diluting the sample with an aqueous component [20]. An SPE method used included the 
addition of internal standard, 800µL of water, 2M sodium acetate buffer, and beta-
glucuronidase to 20µL of urine [21]. This was followed with a one hour incubation step, 
which was then proceeded with cooling to room temperature, centrifugation, and 
automated SPE. Before LC-MS/MS analysis, evaporation to dryness and reconstitution 
were required again contributing to a total sample preparation time of over two hours. 
The limit of quantitation (LOQ) values developed were common with most other studies 
at approximately 0.25ng/mL or 1ng/mL [21]. 
1.3.2.2 Plasma and Blood 
Blood samples, or plasma generated from blood samples, are a useful matrix in 
SC analysis in regards to detection of the parent analytes. Plasma is also a cleaner sample 
in comparison to whole blood. Zaitsu et al. analyzed synthetic cannabinoids in plasma 
collected from centrifuging blood samples obtained from an investigative case [22]. LLE 
and protein precipitation were used to prepare the plasma with an internal standard, 
overnight incubation and enzymatic hydrolysis, vortex and centrifugation steps, 
evaporation, and reconstitution. Though there have been limited studies on the analysis of 
SCs in blood, serum, and plasma, LLE seems to be the most popular extraction method 
chosen for these matrices [6, 17].  
1.3.2.3 Edibles 
The analysis of synthetic cannabinoids in edibles, particularly gummy bear candy, 
has not been investigated. However, there have been studies performed on edibles to 
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analyze other compounds of interest such as dyes and the analysis of natural 
cannabinoids. As a result of the dense, sticky, and colorful nature of gummy bear candies, 
analysis of this matrix can be relatively complex. A study assessing unsulfonated dye in 
sweets, including strawberry gummy bears, heated the sample and implemented a simple 
filtration step through a 0.45µm membrane filter before analysis with high performance 
liquid chromatography (HPLC) [23]. In another study researching natural cannabinoids, 
sample preparation for gummy candy consisted of cutting the sample into fine pieces, 
homogenization, and the addition of water [24]. This mixture was then hydrated with a 
shaker for approximately one hour. After, an acetonitrile solvent and an internal standard 
mixture were added and the sample was shaken in a homogenizer for one minute. Quick 
Easy Cheap Effective Rugged Safe (QuEChERS) extraction salts were added, the sample 
was shaken again, centrifuged, and the acetonitrile layer was diluted via serial dilutions. 
The samples were then analyzed with LC-MS/MS [24].  
1.3.3 Analysis Techniques 
Several techniques have been utilized in synthetic cannabinoid analysis. 
Immunoassays such as enzyme-linked immunosorbent assays (ELISA) and enzyme 
immunoassays (EIA) have been used screening methods of detection in urine [6, 25]. 
Thin layer chromatography (TLC) is a separation technique that has been used on herbal 
SC mixtures.  Znaleziona et al. discussed spectral methods such as nuclear magnetic 
resonance (NMR) and infrared (IR) spectroscopy as useful techniques in the analysis of 
SCs because they are helpful with the “identification of ‘unidentified peaks’”, which can 
be applied in the understanding of the various isomers of the different compounds [6]. 
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However, it was also mentioned that IR is not an ideal method to use on complex 
mixtures because of the extensive isolation steps required beforehand. Nano-liquid 
chromatography, capillary electrophoresis (CE) with ultraviolet (UV) detection and 
ionization techniques such as matrix-assisted laser desorption/ionization (MALDI) and 
direct analysis in real time (DART) are other methods that have been studied in the 
analysis of SCs [5, 6]. MALDI and DART were found to be particularly useful in 
“forensic laboratories in the sense of cost benefit, time savings, and broad applicability” 
but these methods are relatively new and further research is required before they can be 
successfully applied in the analysis of synthetic cannabinoids [6]. 
 Gas chromatography/mass spectrometry (GC/MS) has been a predominant 
instrument studied in SC detection [5, 6, 18]. While mass spectrometry is the method of 
detection most used, flame ionization detectors (FID) and nitrogen phosphorus detectors 
(NPD) have also been coupled with GC for SC analysis. The issues with GC analysis 
include the thermal degradation of some synthetic cannabinoids and some SCs requiring 
derivitization for a more efficient analysis, therefore contributing to an increased overall 
sample preparation and analysis time [6].  The most utilized qualitative and quantitative 
techniques are liquid chromatography and mass spectrometry.  
1.3.3.1 Liquid Chromatography for Synthetic Cannabinoid Analysis 
Liquid chromatography has played a major role in the method development of 
detecting new and existing synthetic cannabinoids. It has been used in both preliminary 
and confirmation methods [6, 7, 19, 21]. Most methods apply C8 or C18 columns with 
particle sizes less than 2µm, a 10-150µm internal diameter (I.D.), and a gradient elution. 
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These parameters enable quicker flow rates, faster analysis, and increased sensitivity [6]. 
The MS parameters include selected-ion monitoring (SIM) and multiple reaction 
monitoring (MRM) modes, however this requires prior information to be known about 
the compounds. Scheidweiler and Huestis discussed mass spectrometry to be useful as a 
screening technique since new SC compounds “may not cross-react in antibody-based 
techniques” while MS also has the ability to incorporate “new analytes as rapidly as 
reference standards become available” [7]. This is a particularly important point of 
emphasis as new synthetic cannabinoids, and therefore certified reference materials, are 
constantly being synthesized and a quick method of detection, or the ability to enter new 
reference information, is necessary as a result. Scheidweiler and Huestis published a 
method that screens for SCs and several metabolites in urine using LC-MS/MS [7]. 
Knittel et al. studied the correlation between parent SCs in blood and their corresponding 
metabolites in urine with LC-MS/MS in addition to successfully identifying and 
quantifying the studied compounds [26]. Jang et al. developed a LC-MS/MS method to 
identify 37 SC metabolites in urine with a focus on the separation of positional isomers 
[21]. There have been a significant number of studies involving the LC-MS/MS analysis 
of SCs, but further method development is continuously desired as new compounds are 
synthesized. 
1.3.3.2 Liquid Chromatography Parameters 
The parameters of reviewed LC-MS/MS studies vary depending on the matrix and 
synthetic cannabinoid evaluated.  Some studies focused on one or two SCs while others 
analyzed over 30 compounds [21, 25]. Many studies assessed the original SC 
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compounds, such as JWH-018, while a limited number of research focused on newer 
compounds. One study found a linear dynamic range of 0.5-10ng/mL using LC-MS/MS 
analysis of human urine samples and Jang et al. determined a range of 2.5-75ng/mL [19, 
25]. LOQ values of 0.1ng/mL and 2.5ng/mL were common in many studies and a LOD 
of 0.1ng/mL for some compounds and 0.025 for other SCs was observed [17, 25, 27]. 
Recovery values varied and ranged from 50-100% [19, 27]. Of all the LC-MS/MS 
methods reviewed, however, multidimensional liquid chromatography analysis of 
synthetic cannabinoids was not observed.  
1.4 The Importance of Method Development for SC Analysis 
1.4.1 Statistics and SC Emergence 
As of May 2016, it was reported that synthetic cannabinoids are “the largest group 
of new psychoactive substances monitored by the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA)” [8]. There is a serious issue with the ability of SCs to 
produce mass poisonings. For instance, in 2015 the synthetic cannabinoid ADB-
FUBINACA was linked to a major outbreak of poisonings in the United States [8]. Even 
with actions taken to schedule SCs, abuse continues to be described in surveys taken 
throughout the country [7]. In 2009, there were only two types of synthetic cannabinoids 
reported, but in 2015 the number of new SCs reported dramatically increased to 84 
compounds [28].  Furthermore, there were 22 synthetic cannabinoids, such as EG-018 
and MDMB-FUBINACA, reported for the first time in 2015 clearly demonstrating the 
rapid emergence of new compounds [28]. In addition to new compounds continuously 
and quickly developing, popularity of other forms such as a SC resin, similar to cannabis 
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resin, has increased [8]. If the resins are more concentrated than the typical amounts of 
SCs sprayed on herbal substrates, the issues associated with mass poisonings may be 
further complicated.  
1.4.2 Analysis 
There are numerous reasons associated with the importance of developing reliable 
methods for SC detection including the number of compounds, increased use, the 
chemical diversity, speed of their emergence, and popularity within many age groups. 
The primary concern with synthetic cannabinoids is lethality. Discoveries such as 
“processing and packaging facilities and large quantities of synthetic cannabinoids in 
Netherlands and Belgium suggests the involvement of organized crime in the distribution 
process,” which has the potential to exacerbate issues [8]. The development of efficient 
sample preparation methods is also necessary for reasons such as matrix effects and the 
ability of other components in a sample to affect the successful detection of SCs [6]. 
Many reports have described increased seizures, manufacturing, and sales of synthetic 
cannabinoids [6, 28].  
Researchers continue to synthesize and search for compounds to use medicinally, 
enabling an easy transition of these compounds to the illicit market [5]. It was also 
emphasized that SC metabolites will not always produce positive results in typical 
screening analyses [16]. This and the continuous emergence of new compounds 
contribute to the difficulty in maintaining reliable and up-to-date detection methods. 
Additionally, the methods that are developed are not all “fully validated and used for 
quantification purposes” [6]. There is a need for the development of selective, sensitive, 
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high throughput, cost-effective, and less time consuming quantitive and qualitative 
analytical methods to successfully detect, monitor, and respond to the issues associated 
with synthetic cannabinoid use [6, 8]. 
1.5 Instrumentation Theory 
1.5.1 Enzyme Immunoassay 
Immunoassay techniques are useful screening methods for several reasons. The 
required materials are readily available for most assays and compounds of interest. For 
example, synthetic cannabinoid testing materials can be purchased from a variety of 
locations including Randox Laboratories, National Medical Services, Immunalysis 
Corporation, Cayman Chemical, and Neogen Corporation [4]. Immunoassay tests are 
quick, inexpensive, have the option for automation, and require minimal sample 
preparation [4]. ELISA is a common immunoassay method utilized while EIA methods 
involve a slightly different technique. EIA can also be described as an enzyme multiplied 
immunoassay technique (EMIT), cloned enzyme donor immunoassay (CEDIA), or 
homogenous enzyme immunoassay (HEIA). EIA techniques use homogenous mixtures, 
competitive antibody binding and drug-drug interactions to analyze samples [14, 29]. The 
competitive description is utilized to represent the fact that there is competition for the 
antibody sites between unlabeled and labeled antigen. In comparison to ELISA testing, 
there are no separation steps required in EIA [29]. Enzyme activity is measured 
spectrophotometrically and absorbance readings are used to produce results. EIA testing 
does not have any washing or incubation steps like ELISA and the materials are provided 
in a format that is ready for use upon arrival with several advantages such as “low matrix 
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effects, reduced sample preparation and high throughput” opportunities [14]. While there 
are many advantages to immunoassay techniques, several non-synthetic cannabinoid 
substances can produce false positive or inconsistent results for a SC test. The “ever-
changing availability” of SCs and the difficulty in the evaluation of cross reactivity 
studies on these novel compounds make it extremely difficult to maintain up to date, 
specific, sensitive, developed, and validated synthetic cannabinoid immunoassay methods 
[4, 14] 
1.5.2 Single Dimension (1D) Liquid Chromatography 
In general, liquid chromatography involves a stationary phase, usually a solid 
such as silica, and a liquid mobile phase, which carries a sample through the stationary 
phase. The components of a sample typically separate based on their affinity to either the 
stationary or the mobile phase. Many LC applications involve the use of reverse-phased 
chromatography where a polar mobile phase and a nonpolar stationary phase, such as 
C18, are implemented [30]. There are many different types of liquid chromatography 
such as HPLC and ultra performance liquid chromatography (UPLC) [31]. There are also 
various separation mechanisms such as liquid-solid partition, which is the most common 
[32]. UPLC can be described as a type of liquid chromatography that utilizes a solid 
phase with smaller particle sizes and maintains higher pressures in comparison to HPLC 
[32]. In UPLC, separations can be performed “5-10 times faster than conventional HPLC 
by employing sub-2µm diameter [stationary phase] particles” enabling better resolution 
efficiency [33]. Liquid chromatography coupled to mass spectrometry is especially 
beneficial in the quantitation and detection of drugs at trace levels.  
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The general layout of a HPLC system includes a sample manager and injection 
port, a high-pressure pump, a solvent reservoir, a column, a detector, and a computer 
[32]. The sample is injected in the sample manager where it meets the liquid mobile 
phase that is being pumped through the column via the high-pressure pump. Then, 
depending on the affinity of the components in a sample to the mobile or stationary 
phase, the components are separated as they move through the column at different rates. 
The detector collects information such as the time the various analytes elute off the 
column and other details that play a role in identification such as mass and charge. This 
information is then processed and visualized, typically on a computer. A liquid 
chromatography unit can be connected to various types of detectors, but the most 
common instrument utilized is the mass spectrometer. 
1.5.3 Mass Spectrometry 
Mass spectrometry is a popular, sensitive method of detection utilized in many 
types of analyses. After a sample goes through the LC component, it is converted to a 
“gas-phase ion” for analysis in the mass spectrometer [34]. MS instruments consist of an 
ion source, a mass analyzer, an ion detector, and a computer. The ion source converts the 
liquid into the gas phase [35]. Electrospray ionization (ESI), like the method used in this 
research, is one example of an ion source where the sample is ionized and formulated into 
an aerosol-like spray from a high voltage [34]. The ionized sample is then accelerated 
through the mass analyzer with an electric and/or magnetic field where the path of each 
ion is redirected according to their mass and charge [35]. A quadrupole mass analyzer, 
the technique utilized in this research, implements an electric field. Triple quadrupole 
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analyzers have four rods with radiofrequency and direct currents enabling ions with a 
specific mass to charge ratio to reach the detector such as those maintained during 
multiple reaction monitoring [36]. The first quadrupole may be set on static mode, which 
allows the passage of certain ions (the precursor ion). The ion then reaches the second 
quadrupole, or collision cell, where Argon gas is used for fragmentation. The third 
quadrupole may also be set on static mode to select particular ions of interest such as the 
product ions created from the precursor ion in the first quadrupole. At the ion detector, a 
vacuum is applied eliminating any unwanted collisions with the ions of the analyte of 
interest. Ion data is organized based on mass-to-charge ratio and relative abundance, 
which is converted to a mass spectrum [34, 35].  
1.5.4 Two-Dimensional (2D) Liquid Chromatography  
A two-dimensional liquid chromatography format can be easily implemented 
from a 1D LC instrument. The main difference between 1D and 2D is the addition of one 
or more columns, valves, and/or pumps. While two columns are generally used to execute 
the two-dimensional aspect, a variety of techniques and concepts can be incorporated to 
perform multidimensional chromatography. In comprehensive chromatography, for 
instance, the second column may be described as “a very chemically selective detector 
for the separation on the first column,” which emphasizes the highly efficient resolution 
capacity multidimensional chromatography can provide [37]. Furthermore, the concept of 
‘heart cutting’ chromatography can be applied where only the “interesting portion” of the 
eluate from the first dimension is transferred to the second [37].  
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Other 2D chromatography techniques may implement AT-column dilution and 
trap/elute concepts, which focus on trapping analytes of interest on the first dimension, or 
trap column, to then perform a more efficient separation of those analytes on the second 
dimension, or analytical column. This was the technique applied in this research. The 
additional pump may be used to provide the AT-column dilution effect pumping an 
aqueous component into a mixture with the organic sample from the injection port [38]. 
This concept enables the injection of 100% organic samples in addition to aqueous 
samples where a dilution takes place at the joining of the loading stream and the dilution 
stream. Upon the mixing of each stream, a dilution of approximately 5% can be achieved 
[38]. This enables the production of more efficient results for compounds that are not as 
soluble or stable in aqueous solvents as may be in 100% organic solvents.   
The trap column may contain particle packing materials of 10µm in size or 
greater, which allows the injection of large volumes and focuses the target analyte. 
Through optimization of loading flow rates, chemistry, and additives, the target analyte 
can be trapped with maximum peak trapping and minimal breakthrough [38]. After 
trapping the analyte of interest, a backflush elution is carried out transferring the desired 
eluate to the analytical column. The analytical column contains much smaller particle 
sizes (2µm) for a more efficient resolution. The chromatography performed on the second 
dimension is then transferred to the detector. The trap/elute concept provides excellent 
separation and specificity with a more efficient workflow in comparison to the limitations 
observed with traditional one dimensional chromatography methods.   
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1.5.5 1D vs. 2D Chromatography 
One of the greatest advantages of 2D chromatography is, perhaps, the ability to 
inject 100% organic samples reducing overall sample preparation time significantly. The 
AT-Column dilution concept enables the injection of 100% organic samples thus 
eliminating the reconstitution and evaporation steps necessary with most SPE preparation 
methods as previously discussed in the reviews of other synthetic cannabinoid analysis 
methods. The time required to prepare samples for LC analysis and any evaporative loss 
are significantly reduced. In this manner, the large number of samples forensic scientists 
have to analyze on a daily basis could be more promptly accommodated. The 
hydrophobic properties of SCs may also play a role in regards to the recovery values of 
samples between 100% organic extracts versus aqueous, reconstituted extracts injected in 
the LC-MS/MS [17]. Some compounds may prefer to be dissolved in 100% organic 
solution without the presence of any aqueous components.  
Larger sized sample injections can also be utilized with 2D-LC-MS/MS. The 
ability of various columns, additives, and solvents to be evaluated with 2D analysis 
provides the opportunity to perform a micro-extraction protocol where analysts can 
“evaluate several elution parameters in a short-time period” such as the completion of 
chromatography optimization in 18 hours [39]. With the extremely high resolving power 
provided by 2D technology, a more efficient analysis of complex samples can be 
achieved with minimal matrix effects. The combination of both dimensions is useful in 
developing sensitive, specific, and robust methods to detect SCs and these factors are 
particularly beneficial with the continuous synthesis of new SC compounds.  
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1.6 Research Objective 
The objective of this research was to develop a reliable, sensitive, and selective 
multidimensional chromatography method to successfully detect and quantify seven 
synthetic cannabinoids in urine, plasma, and edible samples. Rapid sample preparation 
methods were explored to efficiently carry out this objective utilizing a 2D-LC-MS/MS 
instrumentation technique.  
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Synthetic Cannabinoids Evaluated 
This research focused on seven synthetic cannabinoids: XLR-11, AB-PINACA 5-
pentanoic acid metabolite (AB-PINACA 5-COOH), UR-144 5-pentanoic acid metabolite 
(UR-144 5-COOH), 5F-PB-22, AM-2201 4-hydroxypentyl metabolite (AM-2201 4-
OHpentyl met), JWH-018, and JWH-018 5-hydroxypentyl metabolite (JWH-018 5-
OHpentyl met) (Figure 1). The compounds were chosen for analysis based on a list 
developed of the top detected SCs and their common metabolites [12, 21, 25, 27, 40-42].  
 
Figure 1: Structures of Synthetic Cannabinoids Analyzed [43] 
 
25 
2.1.2 Standards and Reagents 
 Synthetic cannabinoid standards and internal standards were obtained from three 
sources. The standards received from Lipomed, Incorporated (Cambridge, MA, USA) 
included UR-144-N-pentanoic acid metabolite 1mg/mL isopropanol (IPA), 5F-PB-22 
1mg/mL acetonitrile (ACN), JWH-018 N-(5-hydroxypentyl) 1mg/mL methanol (MeOH), 
JWH-018 D-11 1mg/mL MeOH, and JWH-018 1mg/mL MeOH. AM-2201 4-
hydroxypentyl metabolite and XLR-11 were from Sigma-Aldrich (St. Louis, MO, USA) 
and both concentrations were 100µg/mL MeOH. AB-PINACA 5-pentanoic acid 
metabolite was obtained from Cerilliant Corporation (Round Rock, TX, USA) in a 
MeOH solution of 100µg/mL. The solvents used were Optima grade and consisted of 
MeOH, ACN, acetone, ammonium hydroxide (NH4OH), hydrochloric acid (HCl), formic 
acid (FA), and phosphoric acid (H3PO4). All solvents were purchased from Thermo 
Fisher Scientific (Waltham, MA, USA). The MilliQ grade water used in this study was 
obtained from EMD MilliporeSigma (Darmstadt, Germany).  
2.1.3 Human Urine Case Samples 
 A total of 17 urine samples that were screened and tested positive for synthetic 
cannabinoids with an EIA test were collected from Clinigen, Incorporated (Woburn, MA, 
USA). These samples were prepared and analyzed with the optimized extraction and 2D-
LC-MS/MS methods developed in this research. Negative urine samples were obtained 
from a non-drug using volunteer. 
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2.1.4 Instrumentation and Software 
 An ACQUITY UPLC® (Waters Corporation, Milford, MA, USA) was utilized in 
2D configuration. The 2D format was prepared with three pumps (Figure 2). The first 
pump, otherwise termed the loader/dilutor, was used to create AT-column dilution. The 
AT-column dilution was produced with two streams – stream A loaded the samples from 
the injection loop into a 50µL mixer while stream B pumped the dilution solvent into the 
mixer at a high flow rate. The second pump was utilized for elution purposes with an 
aqueous and organic stream. The third pump performed a reconditioning step, which 
washed the system with a 1:1:1 acetonitrile/methanol/acetone mixture for two minutes 
and followed with a re-equilibration to bring the system back to its initial loading 
conditions. The detector used to analyze the eluates from the chromatography portion 
was a tandem MS, Xevo TQD (Waters Corporation, Milford, MA, USA) with positive 
electrospray ionization (ESI). Three replicate injections were performed on each sample 
with the average information obtained from the three replicates utilized to complete data 
analysis. 
 MassLynx© version 4.1 and TargetLynx© version 4.1 (both Waters Corporation, 
Milford, MA, USA) were used to carry out analyses on the instrumentation, visualize 
results, and perform data analysis. MassLynx© was used to visualize mass spectrums 
and chromatograms. TargetLynx© was utilized to perform quantitative analysis, such as 
the generation of calibration curves.  
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Figure 2: 2D-LC Fluidic Pathway [38] 
 
2.2 Methods 
2.2.1 Multiple Reaction Monitoring Optimization 
 A 10µg/mL (10ppm) solution of each compound was prepared in 50/50 water: 
MeOH. The solutions were then attached to the MS for direct infusion one by one.  For 
each compound, a precursor ion was determined in MS1 scan mode and two product ions 
were determined in MS/MS mode. The most intense product ion was selected for 
quantification and the second most intense product ion was used as a qualifier. Collision 
energy (CE) and cone voltage were also optimized for each compound. As the CE 
increased, the precursor ion became fragmented and the product ions were visualized in 
the mass spectrum produced. The value at which the signal was the most intense for each 
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transition was chosen for each parameter. All optimized values are displayed in the 
multiple reaction monitoring (MRM) table below (Table 1). Constant MS parameters 
include capillary voltage 3.0kV, 150°C source temperature, 550°C desolvation 
temperature, and desolvation gas and cone gas flow rates of 1100 L/hr and 50 L/hr, 
respectively.  
Table 1: MRM Compound Optimization Table. Transitions were determined for all standards and the 
internal standard. 
Compound Ion Mode 
Precursor 
ion 
 Cone 
Voltage 
Product 
ions  CE 
AM-2201 4-hydroxypentyl 
metabolite ESI+ 376.2 30 155.0 25 
        127.0 30 
JWH-018 ESI+ 342.2 30 155.0 30 
        127.0 30 
JWH-018 5-hydroxypentyl 
metabolite ESI+ 358.2 35 155.0 30 
        127.0 30 
XLR-11 ESI+ 330.2 40 125.1 25 
        97.0 30 
5F-PB-22 ESI+ 377.2 20 232.1 10 
        144.0 30 
UR-144 5-pentanoic acid 
metabolite ESI+ 342.2 30 125.0 20 
        83.0 30 
AB-PINACA 5-pentanoic 
acid metabolite ESI+ 361.20 25 344.2 10 
        316.2 15 
JWH-018 D11 ESI+ 353.2 30 155.0 25 
        127.0 30 
 
2.2.2 Chromatography Method Development 
 Two stock solution mixtures of all SCs were prepared for chromatography 
method development. Mix A consisted of UR-144 N-pentanoic acid metabolite, 5F-PB-
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22, JWH-018 5-hydroxypentyl metabolite, and JWH-018 in 100% MeOH to form a final 
concentration of 10µg/mL. Mix B was prepared with AB-PINACA 5-pentanoic acid 
metabolite, AM-2201 4-hydroxypentyl metabolite, and XLR-11 in 100% MeOH to form 
a final concentration of 10µg/mL. Both mixtures were combined and a serial dilution was 
performed to prepare stock solutions of lower concentration for analysis. Three different 
1ng/mL solutions in MeOH, ACN, and MilliQ water were assessed on different trap and 
analytical columns with different loading and elution conditions throughout this portion 
of the research. With each change made to the previously listed conditions, the following 
remained constant: the sample injection volume was set at 100µL and the samples were 
loaded with water at a flow rate of 0.1mL/min and diluted with water at a 1.9mL/min 
flow rate creating a 5% total dilution. After the loading and diluting steps, the samples 
were loaded onto the trap column at a flow rate of 2.0mL/min. From the trap column, the 
target analytes were re-focused onto the analytical column and eluted at 0.5mL/min flow 
rate with a linear gradient elution 5% organic solvent to 95% totaling a 10-minute run 
time. Some of these conditions were further evaluated at a later date, after optimal 
loading pH, elution solvent, and elution pH were established. 
 Three analytical columns and two trap columns were assessed. All columns 
utilized were from Waters Corporation, Milford, MA, USA. The first analytical column 
was an ACQUITY UPLC BEH (ethylene bridged hybrid) C18, 2.1 x 50mm, 1.7µm. The 
second column evaluated was an ACQUITY UPLC Phenyl, 2.1 x 50mm, 1.7µm. 
Originally, it was determined that the BEH C18 column was the optimal analytical 
column in comparison to the phenyl column. However, after further evaluation and 
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method development, the final column chosen with the best signal intensity and peak 
shape was an ACQUITY UPLC HSS T3 (high strength silica with tri-functional C18 
bonding), 2.1 x 150mm, 1.7µm.  
The two trap columns assessed were an ACQUITY UPLC HLB (hydrophilic-
lipophilic balance), 2.1 x 30mm, 20 µm and an ACQUITY UPLC BEH C8 (n-octylsilyl-
silica), 2.1 x 30mm, 10µm. After data analysis, it was determined that the C8 column 
would provide the best results for this method. This observation was strengthened by the 
fact that HLB columns are strongly hydrophilic, therefore undesirable for retaining 
hydrophobic synthetic cannabinoids. 
 The 1ng/mL samples in water, MeOH, and ACN were run over night with 
combinations of different trap columns and additives in an automated process completing 
chromatography method optimization in 12 hours. Each sample was injected three times 
and the third injection was utilized for analysis during chromatography evaluation. An 
example of one set of permutations is presented below in Figure 3 with water as a loading 
solvent, MeOH as an elution solvent in the top portion of the figure and ACN as an 
elution solvent in the bottom portion. This chromatography optimization was performed 
with a BEH C18 analytical column. Formic acid was used to create pH 3 conditions and 
NH4OH was used to create conditions of pH 10. The same set of conditions was run a 
second time using MeOH as an elution solvent and a phenyl analytical column. It was 
determined that MeOH was a better elution solvent than ACN (Figure 4). In comparison 
to MeOH, ACN signal intensities were lower and peak distortion such as tailing and 
shouldering was prominent.  
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The 2D instrumentation and automated technology enabled the chromatography 
evaluation, over 16 permutations, to be completed in a short amount of time. Overall, it 
was determined that a C8 trap column, pH 10 loading conditions, and a pH 3 MeOH 
elution solvent were the optimal chromatography conditions for synthetic cannabinoid 
analysis. The results of the permutations displayed in Figure 3 are depicted in Appendix 
A (Tables A and B). 
 
Figure 3: 4x4 Method Optimization Scheme 
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Figure 4: Elution Solvent Comparison – ACN vs. MeOH 
 
The solvents and mobile phase additives chosen for the final method can be 
visualized in the XLR-11 chromatograms in Figures 5 and 6. In both figures, the 
conditions that remained the same were the BEH C18 analytical column, BEH C8 trap 
column, and MeOH elution solvent. It is clear upon initial visualization that water is the 
least appropriate solvent to prepare standard synthetic cannabinoid solutions in. Between 
MeOH and ACN, standards prepared with 100% MeOH had slightly higher intensities 
than those prepared with ACN. Furthermore, MeOH was the best overall standard solvent 
for all compounds analyzed in this research (Appendix A).  Figure 5 displays constant pH 
3 loading with pH 3 vs. pH 10 elution conditions. The pH 3 MeOH elution was a whole 
magnitude higher in intensity than that produced with pH 10 MeOH elution. Figure 6 
displays a constant pH 10 load with a comparison of pH 3 and pH 10 elution conditions. 
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Again, the pH 3 eluting condition was a magnitude higher in intensity, with a better peak 
shape than pH 10 elution. Figures 5 and 6 can also be compared to evaluate the difference 
between pH 3 loading and pH 10 loading. Specifically, by observing the chromatograms 
that display MeOH standard solution with a pH 3 elution, it can be concluded that loading 
conditions at pH 10 were slightly higher in intensity compared to pH 3 loading. 
 
 
Figure 5: Chromatography Evaluation A. Constant pH 3 loading – pH 3 vs. 10 MeOH elution. 
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Again, the pH 3 eluting condition was a magnitude higher in intensity, with a better peak 
shape than pH 10 elution. Figures 5 and 6 can also be compared to evaluate the difference 
between pH 3 loading and pH 10 loading. Specifically, by observing the chromatograms 
that display MeOH standard solution with a pH 3 elution, it can be concluded that loading 
conditions at pH 10 were slightly higher in intensity compared to pH 3 loading.  
 
Figure 5: Chromatography Evaluation A. Constant pH 3 loading - pH 3 vs. pH 10 MeOH elution. 
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Figure 6: Chromatography Evaluation B. Constant pH 10 loading - pH 3 vs. pH 10 MeOH elution. 
 
Several columns were explored throughout the method development process. The 
optimal trap column chosen for this method was a C8. Figure 7 depicts different SCs on 
different trap columns under the optimal loading and eluting conditions previously 
discussed. In comparing the C8 trap column to the HLB trap column, it is clear that HLB 
produced results with overall weaker signal intensities, significant tailing and peak 
distortion. Three analytical columns were tested under various conditions. Figure 8 
depicts a comparison between all analytical columns assessed at the optimal loading and 
elution conditions with a C8 trap column. The BEH C18 column was initially chosen 
over a phenyl column due to its slightly higher intensities and better peak shape including 
less tailing overall for the SCs analyzed. After troubleshooting during extraction 
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evaluation, it was ultimately determined that an HSS T3 analytical column would be the 
best choice for analyzing SCs. In comparison to BEH C18, the HSS T3 column had 
stronger signals, tighter bandwidths, and significantly reduced peak distortion. The 
combination of a slightly nonpolar C8 trap column, nonpolar HSS T3 analytical column, 
and a polar mobile phase were used to develop a more robust, reversed-phase liquid 
chromatography method in the analysis of synthetic cannabinoids. 
 
 
Figure 7: Trap Column Comparison – BEH C8 vs. HLB. 
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evaluation, it was ultimately determined that an HSS T3 analytical column would be the 
best choice for analyzing SCs. In comparison to BEH C18, the HSS T3 column had 
stronger signals, tighter bandwidths, and significantly reduced peak distortion. The 
combination of a slightly nonpolar C8 trap column, nonpolar HSS T3 analytical column, 
and a polar mobile phase were used to develop a more robust, reversed-phase liquid 
chromatography method in the analysis of synthetic cannabinoids.  
 
Figure 7: Trap Column Comparison – BEH C8 vs. HLB 
	 36 
 
 
Figure 8: Analytical Column Comparison – Phenyl vs. BEH C18 HSS T3 
 
 
As previously discussed, a comparison of the C18 analytical column to a HSS T3 
column was performed for troubleshooting purposes (Figure 8). Before changing the 
analytical column type, the mobile phases were changed out with fresh solutions and the 
analytical and trap column were replaced with new columns. Furthermore, new standard 
solutions were made in MeOH and analyzed with the improved conditions. However, there 
were still undesirable results such as retention time drift and significant tailing on peaks of 
interest. At that point, the BEH C18 analytical column was replaced with the HSS T3. HSS 
T3 columns have a higher strength silica particle stationary phase with trifunctional 
bonding of C18 enabling a better retention of hydrophobic analytes like synthetic 
cannabinoids. The column temperature, gradient time frame, and flow rates were also 
optimized at this point. The initial expectation of HSS T3 column use would 
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Figure 8: Analytical Column Comparison - Phenyl vs. BEH C18 vs. HSS T3 
 
As previously discussed, a comparison of the C18 analytical column to a HSS T3 
column was performed for troubleshooting purposes (Figure 8). Before changing the 
analytical column type, the mobile phases were changed out with fresh solutions and the 
a l ti l and trap column were replaced with new columns.  Furthermore, new standard 
solutions were made in MeOH and analyzed with the impr ved conditions. How ver, 
there were still undesirable results such as retention time drift and significant tailing on 
peaks of interest. At that point, the BEH C18 analytical column was replaced with the 
HSS T3. HSS T3 columns have a higher strength silica particle stationary phase with tri-
functional bonding of C18 enabling a better retention of hydrophobic analytes like 
synthetic cannabinoids. The column temperature, gradient time frame, and flow rates 
were also optimized at this point. The initial expectation of HSS T3 column use would 
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involve higher retention times of the analytes in comparison to those associated with a 
C18 and phenyl analytical column as HSS T3 contains a high retention stationary phase. 
That was the case in this research; however, higher retention times are not visualized in 
Figure 8 as previously described because the overall method run time was altered 
between evaluation of the C18 column and the HSS T3 column. 
2.2.2.1 Carryover Evaluation 
During the extraction evaluation process, an issue developed where signals were 
absent or significantly low on extracted samples but were easily visualized on the 
unextracted standard samples. Carryover became a point of interest and was evaluated for 
further method optimization. Figure 9 demonstrates a comparison of results with and 
without the reconditioning and re-equilibration steps. There are three water blanks 
following a 10 ng/mL spike under each system. The chromatograms on the left hand side 
clearly portray carryover from the 10 ng/mL spike sample to the blanks. The addition of 
reconditioning and re-equilibration steps successfully eliminated any significant 
carryover as displayed in the chromatograms on the right hand side of Figure 9.  
Therefore, a third pump was added to the LC system to add a wash and 
reconditioning step after each run. Line A was comprised of water and 2% NH4OH and 
line B was prepared with a solution of ACN/MeOH/Acetone. Also, a trap and sample 
manager wash solution comprised of ACN/MeOH/Acetone was prepared. At 7.00 
minutes during the run, line A switched to Line B at a flow rate of 2mL/min for two 
minutes. At 9.00 minutes, line B switched back to line A, which switched the organic 
wash out with a high pH water solution as was determined to be required for loading 
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during chromatography method development. The sample injection volume was also 
adjusted from 100µL to 200µL. The final conditions developed and optimized for this 
method, providing the best signal intensity, resolution, and peak shape, are summarized 
in Table 2.  
 
Figure 9: Carryover Results for XLR-11 
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Table 2: Final Chromatography Conditions 
UPLC Conditions AQUITY UPLC with "Trap and Elute" and AT-Column Dilution conditions 
Injection Volume 200µL 
Loading Conditions MilliQ water + 2% NH4OH (pH 10) 
Loading Flow Rate 2 mL/min 
AT-column dilution 5% 
Trap Column ACQUITY UPLC C8, 2.1 x 30mm, 10µm 
Analytical Column ACQUITY UPLC HSS T3, 2.1 x 150mm, 1.7µm 
Analytical Column 
Temp 70°C  
Mobile phase A Water + 0.5% Formic Acid 
Mobile phase B MeOH + 0.5% Formic Acid 
Elution Gradient 3 minute linear gradient 5% to 95% Mobile Phase B 
Elution flow rate 0.600mL/min 
Wash/Recondition Step 2 minute MeOH/ACN/Acetone wash with 2mL/min flow rate 
Total Run Time 12 minutes 
 
2.2.3 Solid Phase Extraction Method Development 
 Considering the matrices explored, SPE was the method of choice in this research. 
Typically, knowledge of the pKa value of compounds is useful in determining which 
sorbent to start with in SPE evaluation but in the case of SCs, pKa values were not 
known. While chromatography method optimization showed signs of SCs displaying 
some acidic properties, several SPE sorbents were explored. The SPE cartridges 
evaluated included 150mg 6cc Oasis® MCX, Oasis® MAX, and Oasis® HLB (Waters 
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Corporation, Milford, MA, USA). Oasis cartridges contain HLB copolymer based 
sorbents meaning both water and lipid soluble components can be captured. MCX and 
MAX cartridges are two types of Oasis cartridges. They are mixed-mode in the sense that 
they have a reverse phase portion and a strong ion exchange portion. MCX has a strong 
cation exchanger, which is good for performing SPE on basic compounds while MAX 
has a strong anion exchanger, good for retaining acidic compounds. HLB cartridges 
contain strong, hydrophilic, reversed phase sorbents and are useful in SPE on all types of 
compounds. 
  Depending on the acidic, neutral, or basic behavior of the analytes of interest, 
MAX and MCX sorbents can be very useful extraction techniques. The reverse phase 
component consists of silica bonded with C18. The sulfite moiety on the cation 
exchanger of MCX provides a pKa of approximately 1, which enables ionized basic 
compounds to be retained. The ammonium moiety on the anion exchanger in MAX 
sorbents creates a pKa of approximately 14, capturing ionized acidic compounds of 
interest. During SPE on MAX cartridges, a wash containing water and ammonium 
hydroxide removed weak acidic interferences while ionizing acidic compounds of interest 
on the reverse phase portion transferring them to the anion exchanger. A second wash of 
methanol and ammonium hydroxide neutralized basic and neutral compounds causing 
them to elute off of the reverse phased portion. Finally, a mixture of methanol and formic 
acid neutralized the acidic compounds of interest transferring them from the ion 
exchanger to the reverse phase portion for elution. MCX SPE is performed in a similar 
manner using acidic mixtures during wash steps and basic mixtures during elution.  
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Two different solutions at a concentration of 1ng/mL for all SCs were prepared for 
the first extraction optimization. One set contained MeOH as a solvent and the other set 
utilized ACN as a solvent. These solutions were used as unextracted standards, which were 
placed directly into an LC vial for analysis. They were also used as the sample to be 
extracted. In every experiment, unextracted standards were utilized for extraction 
evaluation and recovery comparison purposes. A conditioning step with approximately 
2mL MeOH followed by approximately 2mL MilliQ water was performed in each SPE. In 
each wash and elution step, 2mL of solution were used. The following table represents the 
wash and elution steps carried out in the MCX and MAX applications (Table 3).  
Table 3: Steps for MAX and MCX Solid Phase Extraction 
 
 
 
Evaluation of the MCX and MAX extraction methods concluded the MAX 
sorbent to provide a more efficient extraction in isolating the compound of interest in 
comparison to that of MCX. The initial extraction performed assessed the difference 
between the sample loading at pH 3, pH 7, and pH 10. The loading pH is essential in 
ensuring the analyte of interest is ionized  so that it will be  retained and efficiently 
extracted  from  the sample as a result of its interactions with the sorbent. The loaded 
sample contained 2mL of a spiked standard  1ng/mL solution in MeOH (or ACN) with its 41 
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Evalu tion f the MCX and MAX extraction methods concluded the MAX 
sorbent to provide a more efficient extraction in isolating the compound of interest in 
comparison to that of MCX. The initial extraction performed assessed the difference 
between the sample loading at pH 3, pH 7, and pH 10. The loading pH is essential in 
ensuring the analyte of interest is ionized so that it will be retained and efficiently 
extracted from the sample as a result of its interactions with the sorbent. The loaded 
sample contained 2mL of a spiked standard 1ng/mL solution in MeOH (or ACN) with its 
Cartridge MCX MAX 
Wash 1 0.1 N HCl MilliQ water + 5% NH4OH 
Wash 2 (for MeOH loaded solutions) MeOH + 5% FA MeOH + 5% NH4OH 
Elution (for MeOH loaded solutions) MeOH + 5% NH4OH MeOH + 5% FA 
42 
respective pH additive. The load step, wash 1 (W1), wash 2 (W2), and elution step were 
collected and analyzed for each method. Figure 10 displays a comparison of MCX and 
MAX collected eluates of the metabolites AB-PINACA 5-COOH and UR-144 5-COOH 
at pH 3 MeOH loading. The MAX application to pH 3 loaded samples in MeOH had 10X 
signal intensities compared to that produced from MCX in addition to significantly less 
noise and better Gaussian peak shapes. It was also concluded that MeOH was the best 
solvent to utilize in comparison to ACN.  
Further evaluation of the MCX collections determined there to be a high 
percentage of some compounds of interest eluted in W2, suggesting acidic behavior 
(Table 4). In the evaluation of the MAX collections, it appeared that half of the 
compounds of interest were binding to the ion exchanger portion while the other half 
were binding to the reversed phase component. This can be observed in the split recovery 
percentages displayed between the W2 and the elution step for MAX results in Table 4. 
This observation described potential zwitterion properties of SCs. The data in the table 
was calculated by taking the sum of the average of the three replicate injections for load 
A, W1, W2, and elution. A percent recovery was then calculated for each step by taking 
the average of the three injections and dividing that value by the sum. Overall, zero 
breakthrough was displayed in the MAX collections. The MAX cartridge with low pH 
loading conditions was concluded to provide the best synthetic cannabinoid extraction.  
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Figure 10: A Comparison of MAX and MCX - Solid Phase Extraction Optimization 
44 
Table 4: MAX vs. MCX – MeOH Extraction Recoveries.  
 
MAX Recovery MCX Recovery
pH 3 load (%) pH 3 load (%)
Load A 0.11 Load A 0.39
W1 0.16 W1 0.52
W2 51.44 W2 30.05
Elution MeOH + 5%FA 48.28 Elution MeOH + 5%NH4OH 69.04
MAX Recovery MCX Recovery
pH 3 load (%) pH 3 load (%)
Load A 0.02 Load A 0.07
W1 0.02 W1 0.22
W2 0.32 W2 36.52
Elution MeOH + 5%FA 99.65 Elution MeOH + 5%NH4OH 63.18
MAX Recovery MCX Recovery
pH 3 load (%) pH 3 load (%)
Load A 2.13 Load A 1.36
W1 1.15 W1 0.90
W2 30.51 W2 41.98
Elution MeOH + 5%FA 66.21 Elution MeOH + 5%NH4OH 55.76
MAX Recovery MCX Recovery
pH 3 load (%) pH 3 load (%)
Load A 0.02 Load A 0.03
W1 0.02 W1 0.10
W2 55.81 W2 65.89
Elution MeOH + 5%FA 44.16 Elution MeOH + 5%NH4OH 33.98
MAX Recovery MCX Recovery
pH 3 load (%) pH 3 load (%)
Load A 0.48 Load A 1.28
W1 0.60 W1 1.22
W2 0.16 W2 86.59
Elution MeOH + 5%FA 98.76 Elution MeOH + 5%NH4OH 10.91
MAX Recovery MCX Recovery
pH 3 load (%) pH 3 load (%)
Load A 0.03 Load A 0.02
W1 0.02 W1 0.09
W2 57.63 W2 66.65
Elution MeOH + 5%FA 42.32 Elution MeOH + 5%NH4OH 33.24
MAX Recovery MCX Recovery
pH 3 load (%) pH 3 load (%)
Load A 0.06 Load A 0.05
W1 0.04 W1 0.37
W2 39.54 W2 12.67
Elution MeOH + 5%FA 60.36 Elution MeOH + 5%NH4OH 86.91
5F-PB-22
JWH-018 5-hydroxypentyl
AM-2201 4-hydroxypentyl
AB-PINACA 5-COOH
XLR-11
JWH-018
UR-144 5-COOH
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 The observation of potential zwitterion characteristics of the compound of interest 
suggested further extraction optimization would be necessary. The loading pH was 
optimized as previously discussed, however, the additional parameter of loading solution 
organic strength was assessed with varying pH values for further extraction evaluation. 
The optimization of a combination of parameters, such as loading pH and organic 
strength, is useful in obtaining maximum recovery. Therefore, an extraction was 
performed on an HLB cartridge using elution solvents with varying percentages of 
MeOH. The HLB protocol carried out consisted of the conditioning and loading steps 
previously discussed and an elution step with different solutions of MeOH.  Ten different 
MeOH solutions were used – 10, 20, 30, 40, 50, 60, 70, 80, 90, an 100% MeOH in water 
loaded on ten cartridges yielding ten separate, collected eluates. This experiment was 
performed a second time with the MeOH elution solutions at pH 3 using 0.5% formic 
acid and a third time with the MeOH elution solutions at pH 10 using 0.5% NH4OH. The 
pH 10 elution portrayed zero breakthrough up until 80-90% MeOH while the pH 7 and 
pH 3 elution demonstrated breakthrough at lower percentages of MeOH.  
Table 5 displays the carboxylic acid SCs and their highest recovery percentages 
spread over a variety of pH 3 elution solutions. The recovery percentages of the other five 
SCs at pH 3 elution were spread evenly across all MeOH elution solutions. Table 6 
displays the percentage recoveries of the other five synthetic cannabinoids analyzed. The 
highest recoveries were observed at a range of 80-100% MeOH. The recovery 
percentages of the carboxylic acid SCs at pH 10 elution were spread evenly across all 
MeOH elution solutions. The split recovery percentages from the MAX evaluation and 
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the spread recovery values across different elution solutions of varying MeOH 
percentages and pH values demonstrated the importance of developing a more efficient 
method of extraction in terms of recovery. 
 
Table 5: HLB Extraction - Elution pH 3 
 
Table 6: HLB Extraction - Elution pH 10 
 
 As a result of the HLB evaluation with different MeOH elution solutions, the 
original MAX method previously described (Table 3) was altered to include a different 
W2 solution and elution solvent. The final MAX method is summarized in table 7. Wash 
1 was utilized to wash off any weak interferences and ionize the compounds of interest 
off the reversed phase portion and onto the ion exchanger. Wash 2 removed any 
PH	 Elu'on	Solu'on	
UR-144 5-COOH 
Metabolite 
Recovery (%) 
AB-PINACA 5-COOH 
Metabolite 
Recovery (%) 
3	
Elution 10% MeOH + FA 0.97	 0.47	
Elution 20% MeOH + FA 0.92	 0.33	
Elution 30% MeOH + FA 0.86	 0.17	
Elution 40% MeOH + FA 0.87	 0.78	
Elution 50% MeOH + FA 0.56	 4.33	
Elution 60% MeOH + FA 0.31	 46.32	
Elution 70% MeOH + FA 0.29	 41.24	
Elution 80% MeOH + FA 25.54	 3.92	
Elution 90% MeOH + FA 56.85	 0.84	
Elution 100% MeOH + FA 12.84	 1.61	
PH	 Elu'on	Solu'on	
XLR-11 
Recovery 
(%) 
JWH-018 
Recovery 
(%) 
JWH-018 5-Ohpentyl 
metabolite 
Recovery (%) 
AM-2201 4-Ohpentyl 
Metabolite 
Recovery (%) 
5F-PB-22 
Recovery 
(%) 
10	
Elution 10% MeOH + NH4OH 0.43	 5.40	 0.23	 0.17	 0.39	
Elution 20% MeOH + NH4OH 0.29	 4.30	 0.25	 0.23	 0.39	
Elution 30% MeOH + NH4OH 0.35	 4.05	 0.30	 0.22	 0.53	
Elution 40% MeOH + NH4OH 0.44	 3.91	 0.43	 0.30	 0.50	
Elution 50% MeOH + NH4OH 0.60	 4.63	 0.66	 0.47	 0.84	
Elution 60% MeOH + NH4OH 0.68	 5.73	 0.79	 0.54	 1.09	
Elution 70% MeOH + NH4OH 0.83	 7.73	 0.78	 0.54	 1.33	
Elution 80% MeOH + NH4OH 1.18	 8.59	 1.89	 2.43	 1.37	
Elution 90% MeOH + NH4OH 38.14	 9.06	 32.87	 38.35	 19.14	
Elution 100% MeOH + NH4OH 57.07	 46.61	 61.80	 56.75	 74.42	
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additional interferences while keeping the compounds of interest on the ion exchanger. A 
wash containing 70% methanol in water was ultimately used because in an experiment 
where 80% was used, approximately 5% of the compounds were unable to be recovered 
in the elution. Elution 1 was used to elute any compounds of interest that may have been 
stuck to the reversed phase portion of the sorbent. Elution 2 neutralized the remaining, 
acidic SCs off of the ion exchanger causing those compounds to transfer to the reversed 
phase component and elute off of the cartridge. Two elution steps were utilized to ensure 
the most efficient extraction of the zwitterion analytes was completed. A comparison of 
the original MAX method and the final MAX method was performed and all loading, 
wash, and elution steps were collected and analyzed.  
Table 7: Final MAX Solid Phase Extraction Method Protocol 
Cartridge MAX 
	
Condition 1 ~2mL MeOH 
	
Condition 2 ~2mL MilliQ Water 
	
Load 100mL solution (100mL MilliQ water at pH 3 + 2mL centrifuged sample) 
	
Wash 1 2mL MilliQ water + 5% NH4OH 
	
Wash 2 2mL 70% MeOH in water + 5% NH4OH 
	
Elution 1 1mL 100% MeOH in water + 5% NH4OH Pool elution 1 & 2 together 
collecting a total of 2mL 
sample for analysis Elution 2 1mL 100% MeOH in water + 5% FA 
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 Figure 11 displays a comparison between the original and final MAX methods for 
XLR-11, which provides an overall description of the results for all analytes studied in 
this research. Three samples at a concentration of 0.1, 1, and 10ng/mL MeOH were 
prepared for loading where 2mL of each solution were placed into a plastic centrifuge 
tube with 2mL of MilliQ water. Each sample was then placed into its own tube 
containing 100mL of MilliQ water and 2mL formic acid (to create pH 3 loading 
conditions). Three more samples were prepared the same way with 2mL of urine added to 
each centrifuge tube instead of water, enabling a protein crash to take place.   
 The final 100mL solutions were then loaded on to the SPE cartridges for 
extraction. The chromatograms displayed in figure 11 represent those produced from the 
samples prepared with water added. The final MAX method produced a higher recovery 
in the elution than that portrayed in the elution from the original MAX method. It can 
also be observed that some of the compound of interest is lost in the wash step when 
using the original method, as the wash step has higher signal intensity than the elution. 
The signal intensity of the original method shows loss of compound when comparing the 
intensity of the unextracted standard to the intensity of the extract. The signal intensity of 
the extract obtained from the MAX final method displayed almost 100% recovery in 
comparison to that obtained in the unextracted standard, confirming the efficiency of 
utilizing the MAX final method over the MAX original method in the extraction of 
synthetic cannabinoids.  
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Figure 11: Comparison of MAX Original and MAX Final Methods – XLR-11 
   
2.2.3.1 Urine Sample Preparation Optimization 
 When comparing the MAX final and MAX original methods during extraction 
optimization, it was observed that matrix effects and the way the samples were prepared 
before SPE may have been affecting overall recoveries. For example, Figure 12 displays 
a signal intensity reduction by almost 10X from the unextracted standard to the urine 
extract for AM-2201 4-hydroxypentyl metabolite. The high recovery observed from the 
unextracted standard to the water extract but poor recovery between the water and urine 
extracts suggested binding issues. Other instances showed the compound of interest in the 
unextracted standard, but missing in the extracts.  
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Figure 12: Depiction of Potential Binding Issues Resulting from Protein Crash Preparation 
 
In order to eliminate any binding issues, the protein precipitation method was 
altered to include a glass centrifuge tube instead of a plastic centrifuge tube and 50µL of 
phosphoric acid. All protein crashed samples were centrifuged for five minutes at 
3900rpm. The supernatant was then poured off into 100mL MilliQ water (spiked with 
2mL formic acid to create pH 3 conditions) before loading onto the SPE cartridge for 
analysis.           
 The final method utilized in urine sample preparation consisted of a protein crash, 
dilution, and SPE. The protein crash was performed by adding 2mL of MeOH, 50µL 
phosphoric acid, and 2mL of urine to a 20mL glass centrifuge tube. After capping and 
shaking manually, the samples were centrifuged. The supernatant was then poured off 
into 100mL of MilliQ water to create a dilution of less than 5% and 2mL of formic acid 
51 
were added to create pH 3 loading conditions. The 100mL samples were then loaded onto 
an MAX 6cc 150mg SPE cartridge with a 100mL attachment on it for solid phase 
extraction (see Figure 13). A negative pressure pump was used to help load the samples 
on the column (~10-15psi). The MAX final method was then performed, collecting and 
transferring a 2mL final eluate to an LC vial. Pressure on the wash and elution steps was 
maintained ~5psi. A volume of 20µL internal standard JWH-(018) d11 was added to each 
unextracted and extracted sample before 2D-LC-MS/MS analysis.  
 
Figure 13: 100mL attachment for SPE cartridge 
 
2.2.3.2 Plasma Sample Preparation  
The plasma samples were prepared in a similar manner as the urine samples 
except a slightly higher proportion of MeOH was utilized. A protein crash was first 
100mL 
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performed by adding 3mL MeOH and 50µL phosphoric acid to 2mL of plasma in a 20mL 
glass tube. The tubes were capped, shaken, and centrifuged. The supernatant was 
transferred to 100mL water at pH 3 and processed with the same protocol previously 
described for the urine samples.          
2.2.3.3 Edible Sample Preparation Optimization          
 The edible matrix explored was gummy bear candy (red, green, orange, clear and 
yellow). The complexity of the gummy matrix in comparison to urine and plasma 
required a different type of sample preparation before SPE. The gummy bears were cut 
into fourths, creating ~0.5g pieces. Two-fourths (to make ~1g) of a sample were added to 
four 20mL glass vials with 3mL of 70%, 80%, 90%, and 100% MeOH in water. Eight 
more samples were created in the same manner, four samples contained ACN in water 
and four contained acetone in water. This experiment was repeated two more times, once 
with 4mL and the next with 5mL total solution. From there, observations were made 
regarding sample changes at room temperature, after sonication, and after heating. The 
objective was to completely dissolve the gummy bear sample into solution to ultimately 
carry out SPE in the shortest amount of time possible.      
 There were several differences observed based on the various conditions of each 
sample. There were no significant changes in the room temperature samples in regards to 
dissolution. The MeOH based samples showed fading color on the gummy bears but 
there was not any color observed in the solution. After ten minutes of sonication, color 
and cloudiness were observed in the 70% MeOH, ACN, and acetone solutions but color 
was not observed in the samples with higher percentages of organic solvent (Figure 14). 
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Additionally, the gummy bears in the 70% organic solutions were very sticky after 
sonication. Heating seemed to provide more desirable results overall. After 15 minutes of 
heating the solutions from ~60-80°C, the gummy bears in the 70% MeOH and ACN 
organic solutions were completely dissolved (Figure 14). Since the presence of water in 
the solutions seemed to play a major role in gummy bear dissolution, solutions of 100% 
water and 50/50 water/organic were prepared and evaluated. The gummy bears in all 
5mL solutions were completely dissolved after 15 minutes of heating with the acetone 
solvent taking the longest to complete dissolution (Figure 14).    
 
Figure 14. Gummy Bear Sample Preparation Observations. (A) ACN solutions (5mL) after 10 minutes 
of sonication. (B) 70% MeOH solutions after 15 minutes of heating. (C) 50% organic solutions (5mL) after 
15 minutes of heating. (D) 100% water solutions after 15 minutes of heating.  
 
54 
Further evaluation was completed comparing the heating method to 
homogenization with a Precellys Evolution homogenizer (Bertin Technologies, 
Montigny-le-Bretonneux, France). Solutions of 100% MeOH, 100% Acetone, 100% 
ACN, 100% water, 50% ACN in water, and 50% MeOH in water were prepared. The 
100% organic solutions were only assessed with homogenization as they had already 
been evaluated with heating and resulted in an undesirable dissolution. After 
homogenization with four ball ceramic ball bearings in a 15mL tube for three 90-second 
cycles at 6000rpm, dissolution in the 100% organic solutions was not observed. Figure 15 
depicts the results of various samples after homogenization and heating. The samples 
with 50% organic (ACN and MeOH) and 100% water in both methods appeared to 
produce an efficient breakdown of the complex gummy matrix. An interesting 
observation was that in all experiments ACN solutions formed two layers. Both layers, 
however, were evaluated as one in future extractions.   
55 
 
Figure 15. Comparison of Homogenization and Heating. (A) 100% water samples at 3mL, 4mL, and 
5mL processed via homogenization. (B) 100% water samples at 3mL, 4mL, and 5mL processed via 
heating. The brown color is the result of red and green colored gummy bears whereas red gummy bears 
were the only candy used in A,C, and D. (C) 100% water, 50% MeOH, and 50% ACN samples processed 
via homogenization. (D) 100% water, 50% MeOH, and 50% ACN samples processed via heating. After 
settling, the heated 50% ACN samples formed two layers.  
 
SPE was performed to compare the extraction rates of the 100% water, 50% 
MeOH, and 50% ACN homogenized and heated solutions. After the dissolution method 
was completed, the samples were centrifuged at 3900rpm for five minutes. The 
supernatant was poured off into 100mL of water, which was then loaded onto the 
conditioned MAX SPE cartridges. The solutions containing 100% water took a 
significantly longer amount of time to load through the column (more than 20 minutes), 
while 50% ACN and MeOH samples only took 10-15 minutes. It was additionally noted 
that the color was retained on the column through all loading, washing, and elution steps 
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producing an overall clear solution in the eluate.       
 The 50% MeOH and 50% ACN samples were prepared for 2D-LC-MS/MS 
analysis to determine the best sample preparation method. Approximately 1g of sample 
was dissolved in 5mL of 50% MeOH or 50% ACN in water. The samples were then 
dissolved by heating for 15 minutes at 60-80°C or homogenized in three 90-second 
cycles. After dissolution, the samples were centrifuged for five minutes at 3900rpm and 
the supernatant was poured off into 100mL of MilliQ water with 2% formic acid. SPE 
was performed with the MAX final method and the eluates were transferred to a LC vial, 
spiked with 20µL of JWH-018 d11 internal standard, and analyzed with 2D-LC-MS/MS.    
 Analysis of the 2D-LC-MS/MS results ultimately concluded the method 
dissolving 1g of gummy bear sample in 5mL of 50% MeOH in water by heating to be the 
best sample preparation method. Figure 16 displays a comparison of the homogenized 
and heated samples in 50% MeOH using the unextracted standard samples as a reference. 
Overall, the heated samples had much better Gaussian peak shapes and higher intensities. 
The homogenized samples produced wider peaks, more noise, and in the case of XLR-11 
for instance, a signal reduction of almost 10X compared to that of the unextracted 
standard. When comparing the samples in 50% ACN, heating provided slightly better 
results than homogenization, however both methods resulted in signal reduction and 
intense background noise (Figure 17). Figure 18 presents a comparison between the 
heated samples in 50% MeOH and the heated samples in 50% ACN. Utilizing MeOH as 
a solvent with the heated dissolution technique provided better Gaussian peak shapes, 
more intense signals, and very little background noise in comparison to the other three 
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methods evaluated. Some signal intensity differences were more significant than others, 
such as 5F-PB-22 (Figure 18).  
 
Figure 16: Edible Sample Preparation Optimization – Heated vs. Homogenized 50% MeOH in 
Water Samples 
 
Figure 17: Edible Sample Preparation Optimization – Heated vs. Homogenized 50% ACN in Water 
Samples 
 
58 
 
Figure 18: Edible Sample Preparation Optimization – Heated 50% MeOH vs. Heated 50% ACN 
Samples    
2.2.4 Calibration Curve Generation  
2.2.4.1 Urine and Plasma        
 For quantitation purposes, a calibration curve was produced for all matrices in 
addition to producing a water extract and an unextracted standard curve on the same day 
each matrix was extracted. Eight calibrators, or spiking solutions, with different 
concentrations were prepared for each curve – 0.05, 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, and 
10ng/mL. Stock solutions (A, B, and C) at concentrations of 1000, 100, and 10ng/mL, 
respectively, in MeOH containing all seven synthetic cannabinoids analyzed in this study 
were utilized in the preparation of the calibrators. Table 8 describes the amounts of each 
solution used to prepare the calibrators. Spiking solutions utilized for the water, urine, 
and plasma extracted curves contained 100% MeOH as a solvent. Spiking solutions 
utilized as unextracted standards contained half MeOH + 0.5% formic acid and half 
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MeOH + 0.5% NH4OH to represent the same conditions the extracted samples were 
collected under in (see MAX final method protocol Table 7).  
 The urine calibration curve was generated by preparing eight solutions with the 
final concentrations listed in Table 8. Each solution contained 2mL of negative urine, 
2mL of the respective calibrator solution, and 50µL of phosphoric acid. The plasma 
calibration curve was generated in the same manner, however 3mL of the respective 
calibrator solution was used. The protein precipitation and MAX final method previously 
described were then performed to yield samples for 2D-LC-MS/MS analysis. The 
collected eluates were spiked with 20µL JWH-018 d11 internal standard after extraction.   
Table 8: Preparation of Calibrator Solutions 
Final Concentration 
(ng/mL) 
Stock 
Solution  
Volume Stock 
Solution (µL) 
Volume 
MeOH (mL) 
10 
A 
100 9.9 
5 50 9.95 
2.5 25 9.975 
1 
B 
100 9.9 
0.5 50 9.95 
0.25 25 9.975 
0.1 
C 
100 9.9 
0.05 50 9.95 
 
2.2.4.2 Edibles 
The calibrators for the gummy bear curves were made differently than the plasma 
and urine curves as the preparation methods differed. Approximately 1g of gummy bear 
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sample was added to eight 20mL glass vials. In order to create the optimal 50% organic 
5mL solution, 2.5mL of water and 2.5mL organic solution were added to the 20mL vial. 
The organic solution added consisted of 2mL of the respective calibrator solution 
(prepared with 100% MeOH as described in Table 8) and 500µL of MeOH. The 
calibrators were then heated for 15 minutes at 60-80°C, transferred to 15mL glass 
centrifuge tubes and centrifuged for five minutes at 3900rpm. The supernatant was 
poured off into 100mL of MilliQ water with 2% formic acid. SPE was performed with 
the MAX final method and the eluates were transferred to a LC vial, spiked with 20µL of 
JWH-018 d11 internal standard, and analyzed with 2D-LC-MS/MS.   
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3. RESULTS AND DISCUSSION 
3.1 Calibration Models 
3.1.1 Urine 
 Three curves were generated in the analysis of synthetic cannabinoids in urine. 
An unextracted standard curve, a water extract curve, and a urine extract curve were 
prepared utilizing the eight calibrator solutions previously described in their respective 
matrix (Table 8). A recovery sample prepared at 1ng/mL and a blank were also analyzed 
with the water and urine curves. A calibration curve equation was calculated for each 
compound utilizing the TargetLynx software and a ratio of the internal standard and 
calibrator area counts. A calibration curve with linear and quadratic fit, 1/x and 1/x2, was 
assessed for each analyte in each matrix to determine the best fit curve for each 
compound.  
Table 9 portrays the linear dynamic range, LOD, LOQ, recovery and R2 values of 
the urine curve for each compound. R2 values of 0.995 or greater were calculated for all 
compounds besides the two carboxylic acids, UR-144 5-COOH and AB-PINACA 5-
COOH. Figures 19-21 depict the urine calibration curves produced for XLR-11, JWH-
018, and AB-PINACA 5-COOH. XLR-11 and JWH-018 had a linear dynamic range of 
0.05-5ng/mL while AB-PINACA 5-COOH linear dynamic range was 0.05-2.5ng/mL. 
LOD values were 0.005ng/mL and lower and LOQ values ranged from 0.0005ng/mL to 
0.1ng/mL. The unextracted standard and water extract calibration curves run on the same 
day as the urine curve are displayed in Appendix B for XLR-11. 
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Table 9: Urine Calibration Curve Results  
 
 
Figure 19: XLR-11 Urine Calibration Curve 
 
Compound Polynomial	Type Weight Linear	Dynamic	Range LOD	(ng/mL) LOQ	(ng/mL) R2 Recovery	(%)
XLR-11 Quadratic 1/X 0.05-5ng/mL <0.005 0.005 0.997 98
UR-144	5-COOH	 Quadratric 1/X 0.05-2.5ng/mL 0.05 0.1 0.992 81
JWH-018 Quadratic 1/X 0.05-5ng/mL <0.005 0.005 0.995 97
JWH-018	5-hydroxypentyl	 Linear 1/X 0.05-5ng/mL <0.005 0.005 0.995 94
AB-PINACA	5-COOH Quadratric 1/X 0.05-2.5ng/mL 0.05 0.1 0.993 104
AM-2201	4-hydroxypentyl Quadratric 1/X 0.05-5ng/mL <0.005 0.005 0.997 99
5F-PB-22 Quadratric 1/X 0.05-5ng/mL 0.00005 0.0005 0.996 106
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Figure 20: JWH-018 Urine Calibration Curve 
 
Figure 21: AB-PINACA 5-COOH Urine Calibration Curve 
 
3.1.2 Plasma 
Three curves were generated in the analysis of synthetic cannabinoids in plasma. 
An unextracted standard curve, a water extract curve, and a plasma extract curve were 
prepared with a recovery and blank sample and a calibration curve equation was 
calculated for each curve in the same manner as in the analysis of the urine curves. Table 
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10 displays the linear dynamic range, LOD, LOQ, recovery and R2 values of the plasma 
curve for each compound. Excellent R2 values of 0.995 or greater were calculated for all 
compounds. Figures 22-24 depict the plasma calibration curves produced for UR-144 5-
COOH, AM-2201 4-hydroxypentyl, and 5F-PB-22. All compounds had a linear dynamic 
range of 0.05-10ng/mL. LOD values were 0.05ng/mL or less and LOQ values ranged 
from 0.005ng/mL to 0.1ng/mL. The unextracted standard and water extract calibration 
curves run on the same day as the plasma curve are displayed in Appendix B for XLR-11. 
 
Table 10: Plasma Calibration Curve Results 
 
 
 
Compound Polynomial	Type Weight Linear	Dynamic	Range LOD	(ng/mL) LOQ	(ng/mL) R2 Recovery	(%)
XLR-11 Quadratic 1/X 0.05-10ng/mL <0.005 0.005 0.996 95
UR-144	5-COOH	 Quadratric 1/X 0.05-10ng/mL 0.05 0.1 0.995 96
JWH-018 Quadratic 1/X 0.05-10ng/mL <0.005 0.005 0.996 89
JWH-018	5-hydroxypentyl	 Linear 1/X 0.05-10ng/mL 0.05 0.1 0.995 89
AB-PINACA	5-COOH Quadratric 1/X 0.05-10ng/mL 0.05 0.1 0.995 85
AM-2201	4-hydroxypentyl Quadratric 1/X 0.05-10ng/mL <0.05 0.05 0.996 88
5F-PB-22 Quadratric 1/X 0.05-10ng/mL <0.005 0.005 0.998 102
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Figure 22: UR-144 5-COOH Plasma Calibration Curve 
 
 
Figure 23: AM-2201 4-hydroxypentyl metabolite Plasma Calibration Curve 
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Figure 24: 5F-PB-22 Plasma Calibration Curve 
 
3.1.3 Edibles 
Three curves were generated in the analysis of synthetic cannabinoids in gummy 
bears. An unextracted standard curve, a water extract curve, and a gummy bear extract 
curve were prepared with a recovery and blank sample in addition to calculating a 
calibration curve equation for each curve in the same manner as in the analysis of the 
urine curve. Table 11 displays the linear dynamic range, LOD, LOQ, recovery and R2 
values of the gummy bear curve for each compound. Excellent R2 values of 0.995 or 
greater were calculated for all compounds. Figures 24-26 depict the gummy bear 
calibration curves produced for XLR-11, JWH-018, and AB-PINACA 5-COOH. All 
compounds had a linear dynamic range of 0.05-10ng/mL except UR-144 5-COOH and 
AB-PINACA 5-COOH, which had a range of 0.02-2.5ng/mL. The LOD value for UR-
144 5-COOH was 0.1ng/mL while the LOD values of the rest of the analytes studied in 
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this research were 0.05ng/mL or lower. The LOQ values ranged from 0.005ng/mL to 
0.5ng/mL. The unextracted standard and water extract calibration curves run on the same 
day as the gummy bear curve are displayed in Appendix B for XLR-11. 
 
Table 11: Gummy Bear Calibration Curve Results 
 
 
 
Figure 25: XLR-11 Gummy Bear Calibration Curve 
 
Compound Polynomial	Type Weight Linear	Dynamic	Range LOD	(ng/mL) LOQ	(ng/mL) R2 Recovery	(%)
XLR-11 Quadratic 1/X 0.05-10ng/mL <0.05 0.05 0.996 113
UR-144	5-COOH	 Quadratric 1/X 0.05-2.5ng/mL 0.1 0.5 0.995 94
JWH-018 Quadratic 1/X 0.05-10ng/mL <0.005 0.005 0.995 105
JWH-018	5-hydroxypentyl	 Quadratic 1/X 0.05-10ng/mL <0.005 0.005 0.995 106
AB-PINACA	5-COOH Quadratric 1/X 0.05-2.5ng/mL 0.05 0.5 0.997 63
AM-2201	4-hydroxypentyl Quadratric 1/X 0.05-10ng/mL 0.05 0.5 0.997 104
5F-PB-22 Quadratric 1/X 0.05-10ng/mL <0.005 0.005 0.996 95
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Figure 26: JWH-018 Gummy Bear Calibration Curve 
 
 
 
Figure 27: AB-PINACA 5-COOH Gummy Bear Calibration Curve 
 
3.2 Matrix Effects and Recovery Calculations 
Matrix effects were assessed and recovery calculations were performed for all 
three matrices. Extraction recovery was calculated using a comparison of the area counts 
and ion ratios for the unextracted neat standards and the matrix match extracted 
standards. The ion ratio was determined by dividing the analyte area count by the internal 
standard area count. A recovery value and matrix effects for the water curve run on the 
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same day as each studied matrix were assessed in addition to the recovery value and 
matrix effects from the urine, plasma, and gummy bear curves. The water recovery value 
and matrix effects were evaluated to determine any effects on the analyte recovery 
outside of the matrix such as water or column contaminants. Matrix suppression effects 
were observed in all three matrices and in the water extracts. The suppression was 
calculated as a percentage utilizing the area counts of the internal standard and calibrator 
by comparing the unextracted standard to the extracted standard. The calculated matrix 
effects from the water extracts was 7% suppression. Overall, the suppression effects were 
low and the recovery values for most of the analytes in all matrices were excellent, 
demonstrating the strength of the sample preparation and chromatography methods 
developed and optimized in this research. 
3.2.1 Comparison of Unextracted and Extracted Standards 
A comparison was conducted between the unextracted standard and the water, 
urine, plasma, and gummy bear extracted standards to assess variations in signal 
intensities, background noise, matrix effects, recoveries, and peak shapes. Figure 28 
demonstrates an example of UR-144 5-COOH at 1.0ng/mL as an unextracted standard 
and in the four matrices previously listed. As expected, there was a signal reduction 
between the unextracted standard and the extracts, with some matrices displaying larger 
intensity variations than others. For example, there was only a slight reduction in 
intensity between the unextracted standard and the urine extract, but a signal reduction 
greater than 10X between the unextracted standard and the gummy bear extract. The 
gummy bear matrix presented more background noise and larger signal reduction in 
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comparison to all other matrices assessed. The water extract displayed surprisingly high 
background noise intensity. The background noise varied between the different SCs 
evaluated, for instance, XLR-11 demonstrated less background noise from matrix to 
matrix in comparison to UR-144 5-COOH. 
 
Figure 28: Chromatogram Comparison of UR-144 5-COOH Unextracted Standard and Extracts 
 
3.2.2 Urine 
 A matrix match standard was used to calculated matrix effects and recoveries. 
The urine matrix produced an 8% suppression effect. Figure 29 depicts an example of the 
recovery and matrix effect calculations for UR-144 5-COOH and XLR-11. The first 
column represents the unextracted standards and displays the intensity of the internal 
standard, which was used in the calculations to determine matrix effects. The second 
column displays the water extracts for the internal standard and each compound and the 
third column represents the urine extracts. There is great recovery, approximately 80% 
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and above, between both the water and urine extracts. Furthermore, slight background 
noise can be observed in the chromatograms of the XLR-11 and UR-144 5-COOH urine 
extracts. A signal reduction was demonstrated when comparing the UR-144 5-COOH 
unextracted standard, water extract, and urine extract. The calculated recoveries of all 
analytes in urine are displayed in Table 9 with values including 97% recovery for JWH-
018 and 106% recovery for 5F-PB-22. 
 
 
Figure 29: Matrix Effects and Recovery for XLR-11 and UR-144 5-COOH Urine Extracts 
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3.2.3 Plasma 
The plasma recovery and matrix effects were calculated in the same manner as the 
urine extracts. Plasma extracts displayed 18.9% suppression, which were the highest 
matrix effects of all three matrices analyzed. The recovery values for all seven synthetic 
cannabinoids analyzed in plasma for this research are portrayed in Table 10 with 85% 
recovery for AB-PINACA 5-COOH and 95% recovery for XLR-11.  
3.2.4 Edibles 
Matrix effects and recovery values were also determined for the gummy bear 
extracts in MeOH. A calculated suppression of 6.6% was determined for the gummy 
extracts and recovery values were also calculated as depicted in Table 11. Recovery 
values for some analytes were excellent, such as 113% recovery for XLR-11 in the 
gummy bear matrix while other values were on the lower side of recovery such as 63% 
for AB-PINACA 5-COOH. Results like the relatively low recoveries, higher background 
noise, and smaller linear dynamic range for the carboxylic acid analytes ultimately 
suggested a different approach in sample preparation and 2D-LC-MS/MS method 
evaluation may be necessary to consider in further evaluation of synthetic cannabinoids 
in all matrices.  
3.3 Case Sample Analysis and Quantitation 
 All 17 urine specimens were prepared and analyzed with the optimized sample 
preparation and chromatography methods. Table 12 presents the results and quantified 
values for all specimens assessed. All samples were positive for synthetic cannabinoids. 
An interesting result was that JWH-018 5-hydroxypentyl metabolite was not detected in 
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any of the samples analyzed. Most quantifiable samples contained UR-144 5-COOH or 
AB-PINACA 5-COOH. This observation emphasizes the importance of creating a 
separate sample preparation and chromatography method for a more efficient and 
successful analysis of the carboxylic acid synthetic cannabinoids in urine. A range of 
quantified values were calculated including 0.013ng/mL 5F-PB-22 detected in case 9 and 
high values of 115.76ng/mL and 73.35ng/mL AB-PINACA 5-COOH in cases 1 and 5, 
respectively. AM-2201 4-hydroxypentyl and 5F-PB-22 were detected in several case 
samples but the values were unable to be quantified, as they were less than the LOQ 
value for that particular compound. It was interesting to note that JWH-018, AB-
PINACA 5-COOH, AM-2201 4-hydroxypentyl, and 5F-PB-22 were detected in several 
samples as majority of these samples were screened positive with an immunoassay kit 
that is described to detect XLR-11, UR-144 and their major metabolites [44]. This further 
highlights the importance of developing a method for new and existing SCs as well as 
demonstrates the issue of screening methods missing the detection of illicit substances in 
biological samples.  
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Table 12: Urine Case Sample Results and Quantitation 
 
 Figures 30-32 represent chromatograms for various case sample results. Figure 30 
displays example chromatograms of analytes that were not detected in case 3 in 
comparison to the chromatograms of the 1ng/mL spiked standards for those respective 
compounds. High background noise baselines can be observed for AM-2201 4-
hydroxypentyl, JWH-018, and XLR-11 demonstrating the absence of each analyte. 
Figure 31 displays the chromatograms and concentrations for all six SCs detected in Case 
9 with a comparison to the unextracted standards. AB-PINACA 5-COOH was detected at 
a concentration of 0.12ng/mL and its resulting chromatogram depicts a peak at the same 
retention time with a very similar intensity as that displayed in the chromatogram for the 
0.10ng/mL unextracted standard. Figure 32 represents a great example of the ability of 
the sample preparation and chromatography methods to detect the carboxylic acid 
Case	Number XLR-11 UR-144	5-COOH	 JWH-018 JWH-018																														5-hydroxypentyl	
AB-PINACA														
5-COOH
AM-2201																													
4-hydroxypentyl 5F-PB-22
1 0.037ng/mL <LOQ ND ND 115.76ng/mL ND 0.009ng/mL
2 0.019ng/mL 0.47ng/mL ND ND ND 0.0080ng/mL ND
3 ND <LOQ ND ND 30.42ng/mL ND ND
4 0.011ng/mL ND ND ND ND ND <LOQ
5 0.021ng/mL <LOQ ND ND 73.35ng/mL ND ND
6 0.041ng/mL ND 0.029ng/mL ND ND <LOQ 0.0012ng/mL
7 ND <LOQ 0.019ng/mL ND ND ND 0.0023ng/mL
8 0.020ng/mL <LOQ 0.038ng/mL ND ND ND 0.0026ng/mL
9 0.030ng/mL 0.23ng/mL 0.037ng/mL ND 0.12ng/mL 0.012ng/mL 0.013ng/mL
10 0.012ng/mL 0.16ng/mL 0.0087ng/mL ND <LOQ ND <LOQ
11 ND ND ND ND 0.29ng/mL ND ND
12 0.012ng/mL 1.9ng/mL ND ND 29.15ng/mL ND <LOQ
13 ND 0.27ng/mL ND ND 3.53ng/mL <LOQ ND
14 0.010ng/mL 1.7ng/mL ND ND 0.17ng/mL ND ND
15 ND <LOQ ND ND ND ND ND
16 0.011ng/mL 0.34ng/mL 0.011ng/mL ND 45.13ng/mL ND <LOQ
17 0.014ng/mL 1.2ng/mL 0.017ng/mL ND 0.75ng/mL ND <LOQ
<LOQ:	peak	detected	but	not	quantifiable
ND:	Not	detected
75 
analytes studied in this research. AB-PINACA 5-COOH and UR-144 5-COOH were both 
detected in case sample 17 at a concentration of 0.75ng/mL and 1.2ng/mL, respectively. 
The 1.0ng/mL unextracted standard chromatogram of both analytes have a similar 
retention time and intensity in comparison to that detected and displayed in the resulting 
chromatograms for case 17. The efficiency of the sample preparation and extraction 
methods is also demonstrated in Figure 32 with the resulting case sample chromatograms 
presenting excellent peak intensities, low noise, and Gaussian peak shape. Other case 
sample chromatogram results can be found in Appendix B.  
 
 
Figure 30: Case 3 Results – Chromatogram Examples of Analytes Not Detected 
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Figure 31: Case 9 Results - Chromatograms of All Analytes Detected 
 
Figure 32: Case 17 Results – Chromatograms of Carboxylic Acid Analytes Detected 
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4. CONCLUSIONS 
A 2D-LC-MS/MS method with an optimized sample preparation protocol was 
successfully developed and applied to analyze, detect, and quantify seven synthetic 
cannabinoids in urine, plasma, and edible samples. Furthermore, the overall sample 
preparation time required for each matrix assessed in this research was less than one hour 
including protein precipitation, heating, and SPE steps. Urine samples totaled 15 minutes 
while sample preparation for the plasma and edible samples was completed in 
approximately 30 minutes.  
A urine calibration curve was developed for each analyte with R2 values of 0.992 
and 0.993 for UR-144 5-COOH and AB-PINACA 5-COOH, respectively and a linear 
dynamic range of 0.05ng/mL to 2.5ng/mL. The other five synthetic cannabinoids 
demonstrated R2 values of 0.995 or above with a linear dynamic range of 0.05ng/mL to 
5ng/mL. A suppression effect of only 8% was observed and recovery values for each 
analyte were calculated to be greater than 80%. Synthetic cannabinoids were detected in 
all 17 urine case samples examined with a variety of detected compounds and values. 
XLR-11 was detected at 0.03ng/mL, AB-PINACA 5-COOH at 0.12ng/mL, and UR-144 
5-COOH at 1.9ng/mL in case 9. Analysis of plasma and gummy bear samples was also 
successfully carried out. Plasma curves had a linear dynamic range of 0.05-10ng/mL with 
all R2 values above 0.995, recovery values of 85% or greater, and suppression effects of 
approximately 19%. Gummy bear curves yielded linear dynamic ranges of 0.05-10ng/mL 
and 0.05-2.5ng/mL with R2 values over 0.995, 6.6% suppression effects, and recovery 
values ranging from 63-113%. Relatively low recovery values, reduced linear dynamic 
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ranges, and matrix effects for the carboxylic acid analytes assessed in this research 
suggested an alternative sample preparation and chromatography approach may provide 
more successful results for these particular compound types in all three matrices.  
Ultimately, this research displays the ease of implementing two-dimensional 
technology to a variety of applications, such as forensic casework as demonstrated with 
the urine case samples analyzed with this method. A faster sample preparation method 
with high extraction efficiency was also developed, eliminating the need for the time 
consuming evaporation and reconstitution steps required in most SPE protocols. Method 
adjustments such as those accommodating specific compounds, like the carboxylic acid 
SCs in combination with this method will provide the ability to detect synthetic 
cannabinoids with specific results and significantly lower LOD and LOQ values.   
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5. FUTURE CONSIDERATIONS 
 There are several future considerations to assess in regards to developing the most 
reliable, sensitive, and specific method in the detection of synthetic cannabinoids. An 
investigation of sample preparation that utilizes various acids and bases and compares 
glass versus plastic sample vials may prove to be useful in correcting binding effects or 
matrix effects. For example, the relatively high suppression effects observed in the 
plasma analysis portion of this research may be able to be reduced. Furthermore, the 
addition of an acid or base in the sample preparation of the gummy bear samples may 
yield an overall more efficient extraction and therefore better recoveries, such as with the 
AB-PINACA 5-COOH analyte. Acetonitrile may also be an effective solvent to use as a 
mobile phase with this method for some compounds in comparison to methanol. Further 
consideration by comparing the two, perhaps with the addition of more synthetic 
cannabinoid analytes to the list analyzed, may provide insight as to the best mobile phase 
solvent for each synthetic cannabinoid. 
 An alternative approach to the chromatography and/or sample preparation 
methods to target improved extraction and analysis of the carboxylic acids assessed in 
this research may allow more useful results. For instance, the addition of a derivitization 
step prior to any sample preparation may produce a more suitable form of the carboxylic 
acid based compounds for UPLC analysis. The conversion of the hydroxyl group to an 
amine on THC proved to be a relatively useful method in the analysis of cannabinoids in 
blood in a study performed by Lacroix and Saussereau [45]. With the preparation of a 
derivative compound, the original carboxylic acid based compounds may be more 
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efficiently extracted in the sample preparation method and more easily analyzed, 
especially in regards to ionization efficiency, with the chromatography method developed 
in this research.  
 A method developed to detect and quantify more than seven synthetic 
cannabinoids would provide many benefits as demonstrated by the analysis of the urine 
case samples in this research. The screening method indicated the presence of some SCs 
while the 2D-LC-MS/MS method detected the presence of more synthetic cannabinoids 
than anticipated. The performance of stability studies may provide further insight in 
various aspects of this research. For instance, while the case samples were screened 
positive and successfully tested positive in this method, more compounds may have been 
quantifiable and/or detected if the case samples were tested earlier on. There was a time 
difference of at least six months between the dates the case samples were screened 
positive and the date they were analyzed with the developed and optimized 2D-LC-
MS/MS method. The analysis of negatively screened urine case samples may also 
provide information on the reliability of this method and elements such as carryover may 
be further investigated. Lastly, the analysis of actual plasma and gummy bear case 
samples would provide the best overall assessment of the sample preparation and 
chromatography methods optimized and developed in this research.  
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APPENDIX A: Chromatography Evaluation  
Table A: Chromatography Evaluation Methods 1-8 
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Table B: Chromatography Evaluation Methods 9-16 
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APPENDIX B: Calibration Curves and Chromatogram Results 
 
 
Figure A: XLR-11 Unextracted Standard Calibration Curve (Urine Extraction) 
 
 
 
Figure B: XLR-11 Water Extract Calibration Curve (Urine Extraction) 
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Figure C: XLR-11 Unextracted Standard Calibration Curve (Plasma Extraction) 
 
 
 
Figure D: XLR-11 Water Extract Calibration Curve (Plasma Extraction) 
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Figure E: XLR-11 Plasma Extraction Calibration Curve 
 
 
Figure F: XLR-11 Unextracted Standard Curve (Gummy Bear Extraction) 
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Figure G: XLR-11 Water Extract Calibration Curve (Gummy Bear Extraction) 
 
 
Figure H: Case 10 Results 
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Figure I: Case 11 Results 
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